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INTRODUCTION .I 
Siddha system of medicine is part and parcel of the earliest civilization of the 
southern peninsula of India. The Siddha medical system has been practiced from time 
immemorial by using substances of all possible origins in a way that balances the possible 
harmful effect of each substance. This form of medicine was professed and practiced by 
Siddhars who were aware of the constituents of the body and the mysteries of the mind. 
Their thoughts and teachings were crystallized in the form of a great system of medicine. 
According to Thirumoolar, 
ÁÚôÀÐ ¯¼ø§¿¡ö ÁÕó¦¾É Ä¡Ìõ 
ÁÚôÀÐ ¯Ç§¿¡ö ÁÕó¦¾Éî º¡Öõ 
ÁÚôÀÐ þÉ¢§¿¡ö Å¡Ã¡ ¾¢Õì¸ 
ÁÚôÀÐ º¡¨Å ÁÕó¦¾É Ä¡§Á. 
(Thirumanthiram) 
Siddha system of medicine is not purely a system of medicine; it is a way of life. 
If one goes through the available literatures of ancient Tamil Medicine, one would see 
that it covers all aspects of human life right from, conception in the mother’s womb to 
occurrence of death. It emphasis the regularity and habits of life. The aim of the system is 
to keep the body and mind in good condition. Karpam, Yogam, Pranayamam and 
Varmam are also performed in Siddha system of medicine. Siddha is a life science which 
includes in its fold all the principles governing the mechanism of body and mind in health 
and sickness. Siddhars classified body temperament based on three humoural theory, such 
as Vatham, Pitham and Kapham respectively. The medical heritages of Tamils are 
preserved in the Siddha system. 
§Å÷À¡Õ ¾¨ÆÀ¡Õ ¦ÁøÄ ¦ÁøÄ 
ÀüÀî ¦ºóàÃõ À¡§Ã. 
        (Theran paadal) 
Having known that the medicinal herbs are not enough to cure the certain chronic 
and dreadful ailments completely, the Siddhars have made a thorough study on the utility 
of mineral substances and formulated the medical preparations consisting of Metals 
(ulogham), Inorganic secondary minerals (uparasam), Organic salts (karasaram), Arsenic 
compounds (Paadanam) and there by attained prominence in the field of medicine. 
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Ý¾¸ó¾¢ ¾¡ÐÀüÀï ¦º¡ýÉ¿¡ð ¼¡÷º¢¸¢î¨º 
´¾¡¢Â ãÄ¢Â¢õÁñ ß÷îº¢¸¢î¨º - §Å¾¼Õõ 
ºò¾¢Ãº¡ Ã¡ì¸¢É¢¿¢ º¡ºÃîº¢ ¸¢î¨º¦Âý§Ã 
ãò¾Ãò¾ ¾¡Ìõ ¦Á¡Æ¢. 
                                     -À¾¡÷ò¾ Ì½ º¢ó¾¡Á½¢. 
Siddha preparations are made by using mercury, uparasam (secondary minerals), 
sulphur and other metals, salts and toxic substances such as wax form of medicines 
(mezhugu), medicated oils (chudar thailam), sublimates (pathangam), hardened medical 
stones (Kattu),  calcinated powders (chunnam) etc. 
Preparations are made mainly out of the parts of the plants and trees, mineral and 
also some animal substances. The use of metals like gold, silver and iron powders in 
some preparations is a special feature of Siddha medicine.  
Every year, hundreds and thousands of people develop cancer. In the year 2000, 
approximately 10 million new cases of cancer were diagnosed, and there were 6 million 
cancer-related deaths. Taken together, 22 million people were living with cancer that had 
been diagnosed within the previous 5 years. These figures reflect a 22% increase in 
cancer incidence and mortality in the world in comparison with the year 1990.  
Cancer is projected to become the leading cause of death worldwide in the year 
2010, according to a new edition of the World Cancer Report from the International 
Agency for Research on Cancer. Based on projections, cancer deaths will continue to rise 
with an estimated 9 million people dying from cancer in 2015, and 11.4 million dying in 
2030.  
On a global basis, Cancer is on the rise, and is assuming alarming, dimensions. 
Progressive and disseminated malignant disease has a substantial impact on a cancer 
patient’s quality of life, and many cancer treatments may have severe side effects. The 
rapid increase in the global cancer burden represents a real challenge for health systems 
worldwide. Our ancestors had left us so many hand-outs to treat various types of cancer 
by the way of palm manuscripts. In Siddha system, cancer is mentioned as - Puttru, 
Vippuruthi, Dhurmaangisam, Vansilanthi and so on. The medicine Puttru Pathangam 
mentioned in the Siddha text to treat Puttru is used since quite a lot of years.  
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The consequently, education, training and research in this area have not been 
accorded due attention and support. There is a proverb in Tamil that even the Ambrosia 
will become poison if it taken in excess.  “«Ç×ìÌ Á¢ïº¢É¡ø «Á¢÷¾Óõ ¿ïº¡Ìõ.”  
However, in the early 1500s, it was apparent to the physician, Paracelsus, that “the dose 
differentiates a poison and a remedy” stated more directly, any chemical can be toxic if 
the dose is high enough. 
 According to Siddha literature Puttru pathangam is efficient in management of 
cancer and its related complications. In this aspect Puttru pathangam may be a better 
choice of drug. Since modern society is against the usage of metallic and herbo-mineral 
compounds as medicine these study is more important for its own. The quantity and 
quality of the safety and efficacy data on traditional medicine Puttru pathangam are far 
from sufficient to meet the criteria needed to support its use. 
Here, we take the opportunity to reveal the important of this medicinal preparation 
and its toxicity evaluation by animal experiment. This anchoring in identity, added to the 
renewal of interest in such traditional medicines, contributes to the revitalization of 
Siddha to all life worldwide. 
It is time to truly begin our work on bringing our Siddha Traditional medicine - 
for Puttru and create an equitable system of health to the Society. The future 
possibilities for the integration of traditional medicine place us at an exciting juncture. 
This claim is especially relevant in the case of mercury which is relatively often 
used in the system; medicine containing purified mercury should only be received, if at 
all, from a highly qualified practitioner of the art.  
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               AIM AND OBJECTIVES. II 
AIM 
The aim of this study is to evaluate the safety profile of Puttru Pathangam. 
OBJECTIVES 
Based on the literature evidences, various sources of ingredients have been 
collected and purified. After that, the preferred of ingredients will be chosen and used in 
the preparation of Puttru Pathangam as per literature. Then, the finished product of Puttru 
Pathangam is sent for elemental analysis to estimate the presence of any heavy metals and 
other organic and inorganic compounds.  
To analysis its safety, Puttru Pathangam is subjected for Acute oral toxicity and 
Repeated oral toxicity evaluation under OECD guideline on rodents. 
Puttru Pathangam has been evaluated in the following aspects: 
· Collection of relevant literatures regarding the ingredients of the study 
drug. 
· Getting authentication of raw drugs.  
· Purification process of ingredients of Puttru Pathangam. 
· Preparation of Puttru Pathangam as per textual method.  
· Evaluation of physico-chemical analysis in Puttru Pathangam. 
· Elemental analysis of Puttru Pathangam 
· Safety study of Puttru Pathangam on rodents. 
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 REVIEW OF LITERATURE.III 
3.1 RASAM  
(Hydrargyrum, Mercury) 
Introduction: 
 Rasam, Hydrargyrum(Hg) - one of Pancha Sootham, is obtained in large 
quantities from China and Japan both in its native state and combined with sulphur as 
Cinnabar or red sulphide of mercury. Mercury means life. It is supposed to produce gold 
from base metals. It is called the expelles of diseases. It occupies central place in Siddha 
medicine and it could make the body resistant and immortal. It is mentioned as Karpam, 
Sootham, Sathu, Bharatham, Sivam, Saaru etc. The mercury obtained from Lingam 
(Cinnabar) is considered as pure and suitable for medicinal purposes. 
General properties of Rasam: 
 Å¢Æ¢§¿¡ö ¸¢Ãó¾¢ÌýÁõ ¦ÁöîÝ¨Ä ÒñÌð 
¼Æ¢¸¡Ä¢ø Å¢óÐÅ¢É¡ø «ò¨¾ - ÅÆ¢Â¡ö 
Ò¡¢ÔÅ¢¾¢ Â¡Ð Ò¡¢Ô§É¡ ¦ÂøÄ¡õ 
þ¡¢ÔÅ¢¾¢ Â¡Ð Á¢ø¨Ä. 
    (Gunapaadam, Thathu-Jeeva vaguppu) 
 Proper use of mercury as medicine cures the diseases of eyes, syphilis, eight types 
of ulcers (Gunmam), throbbing pain (Soolai), chronic ulcer (Perum pun) and Hansens 
diseases (Thozhu noi). 
Purification methods: 
No medicine is so often found adulterer as mercury. Purification is very important 
before the drug preparations. So many methods are explained in the text. 
 1. Rasam (35gms) is taken in a mud pot and 166.5gm of Thumbai (Leucas aspera) 
whole plant juice is poured and it is kept in Sunlight for 10 days. Fresh juice of Thumbai 
is added daily. After completion, the Rasam containing pot is dried without the juice. 
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 2. Rasam is taken in a Bronze vessel and mixed with Manjal (turmeric) powder, 
and filtered by using a clean cloth. 
 3. Required quantity of mercury is placed in a thick cloth and squeezed for 1000 
times. Then it is placed in a earthen pot. Fresh water is poured in the earthen pot up to the 
level of 1inch above the mercury level. The pot is heated with low intensity fire. The 
water level is maintained by adding water. When the water turns into black in colour, the 
mercury is separated and washed with vinegar for 4 or 5 times to get the purified and 
detoxified mercury. 
Beneficial properties: 
 It purifies blood.  
 It improves Blood and Sperms 
Stimulates appetite 
It cures the diseases of the internal and external organs of the body 
It improves facial complexion 
It improves memory power, eradicates amnesia 
It strengthens the nerve plexuses. 
It develops wisdom through concentration of mind 
It prevents senility and increases the life span. 
Harmful properties of impure mercurial preparation: 
 If the medicinal mercury is not purified properly, the disease like bleeding, 
dropsy, anaemia, excessive body heat, sweating, diarrhoea, thirst, flatulence, blabbering, 
skin diseases burning sensation of the limbs head diseases, fever, shivering, hiccough etc., 
will manifest and finally death will occur. The whole body will be burnt and all the teeth 
will fall down. 
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Antidotes for Mercury: 
 If the mercurial poison affects the gluteal region, Sayapattai (dye plant root bark) 
is powdered and given along with jaggery. 
 For Fixation of teeth and jaws, the stem juice of Kovai thandu (Coccina indica) 
may be poured on the tongue.   
 If there is burning sensation in limbs, urticaria, dryness of the throat and the 
patient is unconscious (amnesia), Arugan kizhangu (Cynodon dactylon) is triturated and 
dissolved in goat’s milk or cow’s milk or butter milk, or cotton seed milk is filtered and 
administered.  
§º¡¢Ã¾í ¦¸¡ñ§¼¡÷ìÌî ¦ºôÒÅ¡ö ¦Åñºí¸¢ý  
º¡È¡Ìí ¸¡ÃÅøÄ¢î º¡È¡Ìõ - º£÷¿£Ä¢ 
¿ø§Å¨Ã ¦Åó¿£¡¢ø ¿üÍñ¨¼ ¸¡ÂÇ× 
Óó¿¡ ÇÕó¾ø Ó¨È.                               
      (Agathiyar vida pirathi vida thirattu) 
 The leaf juice of Vellai Mutsangu (Azima tetracantha) or MithiPaaghal 
(Momordica muricata) 80ml oraly twice a day for 3 days. 
Avuri (Indigofera tinctoria) root bark is triturated with hot water and made into 
poultice. It is given in the size of Sundaikaai twice a day for three days. 
Some preparations: 
1. Veera mezhugu 
Dosage  : 65-130mg 
 Anupaanam  : palm jiggery. 
 Therapeutic uses : Nachu Paandu, Mahodharam. 
 *Reference: Anoboga vaithiya navaneetham. 
2. Akkini kumara mathirai 
 Dosage  :  65mg. 
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 Therapeutic uses : Paandu, Sobai, Kaamalai. 
 *Reference: Kannusamy parambarai vaithiyam, pg no: 234. 
3. Dasamuga udaya akkini chenduram  
Dosage  : 488mg. 
 Anupaanam  : Ghee, Honey. 
 Therapeutic uses : Paandu, Sobai, Kaamalai. 
 *Reference: Sikicha rathna deepam, pg no: 264. 
4. Soodha parpam 
Dosage  : ½ - Kundri. 
 Anupaanam  : Ghee, Honey. 
 Therapeutic uses : Mega viranangal, Kiranthi, Korukku. 
 *Reference: Sikicha rathna deepam, part 2-Vaithiya chinthamani, pg no: 216. 
5. Pancha Paadana chenduram 
Dosage  : Arisi edai. 
 Duration  :  5-7 days. 
 Therapeutic uses : Puttru, Kuttam, Sanni, Solai. 
 *Reference: Sikicha rathna deepam,part 2- Vaithiya chinthamani, pg no:229. 
 
MERCURY 
Introduction: 
Mercury is a metallic chemical element identified by the symbol Hg on the 
periodic table. It is silver in colour and, unlike other metals, is liquid at room temperature. 
The ancient name for mercury was quicksilver, meaning "living" silver. This name 
reflected mercury's lustrous silver colour and its unusually lively behavior: when it is 
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poured onto a smooth surface, it forms beads that roll rapidly around. The element's 
modern name comes from Mercury (Mercurius), the fleet-footed messenger of the gods in 
Roman mythology. 
 
Scientific classification: 
Name    : Mercury  
Symbol   : Hg  
Atomic Number   : 80  
Atomic Mass   : 200.59 amu  
Melting Point   : -38.87 °C (234.28 K, -37.966 °F)  
Boiling Point   : 356.58 °C (629.73 K, 673.844 °F)  
No. of Protons/Electrons : 80  
No. of Neutrons  : 121  
Electron configuration : [Xe] 4f14 5d10 6s2 
Classification   : Transition Metal  
Crystal Structure  : Rhombohedral  
Density at 293 K  : 13.456 g/cm3  
Colour    : Silver 
Source:  
· Mercury's presence in the Earth's crust is relatively low compared to other 
elements. However, mercury is not considered rare because it is found in large, 
highly concentrated deposits.                                                                             
· Nearly all mercury exists in the form of a red ore called cinnabar, which is 
composed of mercury and sulphur.  
· Sometimes shiny globules of mercury appear among outcrops of cinnabar, which 
is probably why mercury was discovered so long ago. The metal is relatively easy 
to extract from the ore by applying heat and a filtration process.  
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· First the ore is heated in an oxygen furnace. The mercury is released as fumes and 
those fumes condense into soot on a water-cooled metal condenser. The mercury 
is then removed from the soot by a filter system and purified in a vacuum.  
· Much of the world's mercury has traditionally been mined in Spain and Italy, 
though several other countries also produce commercial quantities. 
Uses of Mercury: 
· Mercury is used in barometers and manometers (instruments for measuring the 
pressure of gases and liquids), because of its high density. 
· The metal also has a high rate of nearly linear thermal expansion, so it is used 
extensively in thermometers. 
· Its ease in amalgamating with metals is made use of in extracting gold, silver, and 
platinum from their ores. 
· Mercury is widely used in making advertising signs, mercury switches, mercury-
vapour lamps and other electrical apparatus. 
· Various compounds of mercury are used in medicine, dentistry, cosmetics 
(mascara) and also in agriculture to make fungicides. 
TOXICOLOGICAL ASPECTS: 
Mercury is a metallic element that occurs naturally in the environment. There are 
three primary categories of mercury and its compounds: 
 
Ø Elemental mercury, which may occur in both liquid and gaseous states; 
Ø Inorganic mercury compounds, including mercurous chloride, mercuric 
chloride, mercuric acetate, and mercuric sulfide; and organic mercury 
compounds.  
Action: 
 The mercuric ion binds with the sulphydryl groups of enzymes and cellular 
proteins, mitotic apparatus interfering with enzyme and cellular transport functions. It is 
rapidly converted to mercuric ions in the blood which can lead to renal tubular damage.  
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Toxicokinetics of elemental mercury by the human body 
Elemental 
form of Hg 
Ways of toxicokinetics by the human 
Organism 
References 
Absorption 
and 
adsorption 
The respiratory absorption of elemental 
mercury is the major way of absorption in 
humans (>75-85% of the total uptake). 
Through the lungs it is eventually 
transported to the bloodstream. Gastro 
intestinal tract absorption is negligible 
(0.01%). 
Loredo et al., 2003; 
DeRouen et al., 2002; 
Finkelman et al., 
2002. 
Excretion Elemental Hg is excreted from the human 
body in the urine, feces, expired air, sweat 
and saliva. Variations of the form of 
excretion depend on the degree of oxidation 
of elemental Hg to mercuric mercury. In 
general, a low level exposure is related to a, 
mainly, fecal excretion, while a high-level 
exposure is related to a mainly urinary. 
Roels et al., 1991. 
Distribution 
 
It is mainly transported by red blood cells 
(>98% of the total uptake) and accumulates 
mainly on the cerebral gray matter 
(especially the fetal during pregnancy). 
US EPA, 1997c; 
Hursh et al., 1988. 
Biological 
action 
 
It easily enters tissue and red blood cells 
where is oxidized to bivalent mercury, with 
the help of a catalase. 
Halbach and Clarkson, 
1978. 
Affected 
organs 
In a brief, high-level exposure, the lungs. In 
a long-term exposure the Central Nervous 
System (CNS) and especially the brain. 
Karimi et al., 2002; 
Adams et al., 1983. 
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Detoxification 
and 
suppression 
Vitamin E is reported to be a protective 
agent. Additionally, ethanol reduces the 
human organism ability for absorption of 
elemental mercury, possibly by suppressing 
the activity of the catalase, which oxidizes it 
to produce bivalent Hg. Tellurium also 
appears to have a protective role. 
Dunn et al., 1981. 
Borderline 
concentrations 
No symptoms reported on <10 µg Hg m-3 
of air. Symptoms of micro-mercurism on 
10- 50 µg Hg m-3 of air.  
Symptoms of mercurism on 60-100 µg Hg 
m-3 of air.  
Symptoms of the CNS 100-270 µg Hg m-3 
of air.  
A concentration of 10-70 µg g-1 (w/w) in 
the kidneys causes proteinuria. 
Concentrations of 70-140 µg l-1 in the 
bloodstream or 300-600 µg l-1 in the urine 
cause tremor. 
US APA, 1997c; 
Stratis and 
Zachariades, 1989; 
Pavlogeorgatos, 
2001. 
 
In General: 
Elemental mercury is lipid soluble and easily penetrates biological membranes, 
including the blood–brain barrier. Metabolism of mercury compounds to other forms of 
mercury can occur within the tissues of the body.  
Elemental mercury can be oxidized by the hydrogen peroxide-catalase pathway in 
the body to its inorganic divalent form. After exposure to elemental mercury or inorganic 
mercury compounds, the main route of excretion is via the urine.  Determination of 
concentrations in urine and blood has been extensively used in the biological monitoring 
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of exposure to inorganic forms of mercury; hair mercury levels do not reliably reflect 
exposure to elemental mercury or inorganic mercury compounds. 
Neurological and behavioural disorders in humans have been observed following 
inhalation of elemental mercury vapour, ingestion or dermal application of inorganic 
mercury-containing medicinal products, such as teething powders, ointments, and 
laxatives, and ingestion of contaminated food.  
Specific neurotoxic symptoms include tremors, emotional lability, insomnia, 
memory loss, neuromuscular changes, headaches, polyneuropathy, and performance 
deficits in tests of cognitive and motor function.  
Although improvement in most neurological dysfunctions has been observed upon 
removal of persons from the source of exposure, some changes may be irreversible.  
Acrodynia and photophobia have been reported in children exposed to excessive 
levels of metallic mercury vapours and/or inorganic mercury compounds. As with many 
effects, there is great variability in the susceptibility of humans to the neurotoxic effects 
of mercury. 
The primary effect of long-term oral exposure to low amounts of inorganic 
mercury compounds is renal damage.  
Inorganic forms of mercury have also been associated with immunological effects 
in both humans and susceptible strains of laboratory rodents, and an antibody-mediated 
nephrotic syndrome has been demonstrated through a variety of exposure scenarios.  
At high levels of exposure, elemental mercury induces adverse effects in most 
organ systems in the body. Respiratory failure, cardiac arrest, and cerebral oedema are the 
causes of death in fatal cases. 
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3.2 GANDHAGAM  
(Sulphur) 
Introduction: 
 Gandhagam is a Paadanam which exists as a natural production and occurs 
abundantly. It is also known as Sakthi, Kaarilayin naatham, Naatham, Naatram, etc. It is 
bitter and astringent in taste. Its actions are laxative, tonic and antiseptic. It increases 
various secretions of body including skin. It is excreted through sweat, milk and urine.  
 It is of four different types as Pirappu, Vaippu, Kolithalai vaippu and 
Vaanaganthi vaippu. 
Therapeutic Uses:  
¦¿øÄ¢ì¸¡ö ¸ó¾¢ìÌ ¿£ûÀ¾¢¦Éñ Ìð¼Áó¾õ 
Åø¨Ä ¸Å¢¨ºÌýÁ Å¡Ô¸ñ§½¡ö - ¦À¡øÄ¡ 
Å¢¼ì¸ÊÅý §Á¸§¿¡ö Å£ÚÍÃõ §À¾¢ 
¾¢¼ ì ¸¢Ã¸ ½£¸Àõ§À¡ó §¾÷. 
     (Gunapaadam, Thathu-Jeeva vaguppu) 
 
 It is considered to useful in the treatment of 18 types of skin diseases, liver 
enlargement, abdominal distension, eye diseases, chronic venereal diseases, chronic 
diarrhoeas, gastric ulcer, poisonous bites, fever due to vatham, etc. 
 Gandhagam is chiefly used in scabies and other skin diseases both as an external 
and an internal remedy. The fumes of burning sulphur are said to cure gout and rheumatic 
affections. 
 When it is mixed with coconut oil, it is applied to itches and sores; with neem oil 
to rheumatic affections and with gingili oil and with powdered black cumin seed, it is 
given internally for venereal herpes.  
Gandhaga Parpam is prescribed for leprosy, jaundice, contracted limbs, venereal 
diseases, psychiatric disorders (Pramai) etc. 
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Purification methods: 
Gandhagam is used in medicine only after it is purified and cleaned according to 
the rules laid down in Tamil medical science. 
1. The Karkam of Lawsonia inermis (Maruthonri) is mixed in cow’s curd and 
placed in a mud pot. The mouth of the pot is covered with a cloth. Sulphur is placed over 
the cloth. The pot is covered with another pot and burried in the ground. The outer pot is 
subjected to Pudam with five cow-dung cakes. The Sulphur which melts and settles down 
is collected. This procedure is repeated for seven times. 
2. Sulphur is placed in an iron spoon.  A small quantity of cow’s butter is added 
and the spoon is heated till the butter melts; this mixture is immersed in inclined position 
in cow’s milk. This procedure is repeated for 30 times to get purified sulphur. For each 
time of the process, fresh milk is to be used. 
3. Sulphur is melted in the stem juice of Plantain (Vaazhai) tree for ten times to 
get it purified.   
Toxic symptoms of Gandhagam: 
Sulphur is not a highly toxic substance. Improperly purified and irregularly 
prepared Sulphur medicine if consumed over a long period then it causes toxic effects. 
Yellowish discolouration of conjunctiva, Pallor of the face, Discolouration of 
skin like ridged guard flower (Peerkku), Disfigured blackish teeth, Urine like goat’s 
urine, Smoke like odour in the mouth. Feeling of hungry, stomach pain and distension, 
Eruption on the body are some of the toxic symptoms. 
Antidotes for Gandhagam:  
¦ºöÂ¸ó¾¢ ¾¢ý§È¡÷ìÌî ¦ºôÒÅ¡ Â¡Å¢Ãõ§Å÷ 
¨¾§Å¨Ç §Å÷¿£Ä¢ ¾ýãÄõ - ÐöÂÍìÌ 
¿øÄ ÀÕò¾¢Â¢¨Ä ¿¡§¸ÍÃõ ºÁÉ¡ 
ÁøÄ ÌÊ¿£¡¢ðÎ Å¡÷. 
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Å¡÷ôÀ¡ Â¢Ç¿£¡¢ø Åñ¼¡ Á¨ÃÅ¢¨¾¨Â 
§¿÷ôÀ¡ Â¨ÃòÐÅÊ ¿£ÕñÀ¡ö - ¸¡÷ôÀ¡É 
¿ýÁ¢ÇÌ ¿£Ä¢Â¢ý§Å÷ ¿üº£ Ã¸ïºÁÉ¡õ 
ÁýÉ£¡¢ü ¸¡öîº¢Â¨¾ Á¡ðÎ.                    
 (Agathiyar vida pirathi vida thirattu) 
1. Root bark of Cassia auriculata (Avarai), Gynandropis pentaphylla (Thaivaelai), 
and Indigofera tinctoria (Avuri), Dry ginger (Chukku), Cotton leaves and Mesua 
Ferrea flower (Sirunagapoo) are taken in equal parts and the  decoction is 
prepared. 
2. Paste of Thaamarai seeds (Lotus) in tender coconut water also used as an antidote. 
3. Decoction is made by boiling pepper, Indigofera tinctoria (Avuri) root bark and 
Cumin seeds and it is given. 
4. 10 grams in each of Solanum nigrum (Manathakkali) root bark, Piper longum 
(Thippili) and Glycyrrhiza glabra (Athimathuram) are made in to a decoction and 
given. 
5.  If cow ghee is continuously taken in, the victim will be relieved from the effect of 
sulphur poison. 
Some preparations containing Ganthagam: 
1. Koada sooli mathirai 
 Dosage   : Kundri. 
 Anupaanam  : Ghee. 
 Therapeutic uses  : Atta gunmam, Vayu rogam.  
 *Reference: Sarabaenthirar vaithiya muraighal – gunma roaga sikichai. 
2. Sura mathirai 
 Dosage   : Pana eadai. 
 Anupaanam  : Notchi extract. 
 Therapeutic uses  : Suram 
 *Reference: Attavanai vaagadam, pg no: 192. 
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3. Silokya chinthamani 
 Dosage   : Kudriyalavu; 40 days. 
 Anupaanam  : Honey. 
 Therapeutic uses  : Vatha, Pitha and Kapha diseases. 
 *Reference: Vaithiya sinthamani, pg no: 128. 
 
4. Vaaivu Kudori 
 Dosage   : Kundriyalavu; 3 days. 
 Anupaanam  : Ginger extract. 
 Therapeutic uses  : Kuttam, Peenism, Elaippu, Erumal. 
 *Reference: Vaithiya sinthamani, pg no: 128. 
 
5. Kaala megha narayana Chenduram 
 Dosage   : 1/4 -1/2 kundri; twice a day. 
 Anupaanam  : Thuthuvalai kirutham for 15 days. 
 Therapeutic uses  : Silethuma rogam 20, Vaatha rogam. 
 *Reference: Sikicha rathna deepam, pg no: 247. 
SULPHUR 
Introduction: 
 Sulphur is a multivalent non-metal, abundant, tasteless and odourless. In its native 
form sulphur is a yellow crystalline solid. In nature it occurs as the pure element or as 
sulfide and sulfate minerals. Although sulphur is infamous for its smell, frequently 
compare to rotten eggs, that odour is actually characteristic of hydrogen sulphide (H2S).  
 Sulphur occurs naturally as the pure element (native Sulphur) and 
as sulfide and sulfate minerals. Elemental Sulphur crystals are commonly sought after by 
mineral collectors for their distinct, brightly colored polyhedron shapes.  
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Description: 
Symbol   : S 
Atomic number  : 16 
Atomic mass  : 32.06 g.mol -1 
Density   : 2.07 g.cm -3 at 20 °C 
Melting point  : 113 °C 
Boiling point  : 445 °C 
Isotopes   : 5 
Electronic shell   : [Ne] 3s23p4 
Standard potential : - 0.51 V 
Occurrence: 
· On Earth, elemental Sulphur can be found near hot springs and volcanic regions in 
many parts of the world, especially along the Pacific Ring of Fire; such volcanic 
deposits are currently mined in Indonesia, Chile, and Japan. 
Historically, Sicily was a large source of Sulphur in the Industrial Revolution.  
· Common naturally occurring Sulphur compounds include the sulfide minerals, 
suchas pyrite (ironsulfide), cinnabar (mercurysulfide), galena (leadsulfide),sphaler
ite  (zinc sulfide) and stibnite (antimony sulfide); and the sulfates, such as gypsum 
(calcium sulfate), alunite (potassium aluminium sulfate), andbarite (barium 
sulfate).  
History: 
· A natural form of Sulphur known as shiliuhuang was known in China since the 
6th century BC and found in Hanzhong.  By the 3rd century, the Chinese 
discovered that Sulphur could be extracted from pyrite. (Zhang,) 
· Indian alchemists, practitioners of "the science of mercury", wrote extensively 
about the use of sulphur in alchemical operations with mercury, from the eighth 
century CE onwards (White, David Gordon).  In the rasaśāstra tradition, sulphur is 
called "the smelly," (Skt. gandhaka). 
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· Being abundant in native form, Sulphur was known in ancient times, mentioned 
for its uses in ancient India, ancient Greece, China and Egypt.  
· Fumes from burning Sulphur were used as fumigants, and Sulphur-containing 
medicinal mixtures were used as balms and antiparasitics.  
· Sulphur is referenced in the Bible as brimstone (burn stone) in English, with this 
name still used in several nonscientific tomes (Greenwood, N. N.).  
· It was needed to make the best quality of black gunpowder. Elemental Sulphur 
was once extracted from salt domes where it sometimes occurs in nearly pure 
form, but this method has been obsolete since the late 20th century. 
Applications 
· The major derivative of sulphur is sulphuric acid (H2SO4), one of the most 
important elements used as an industrial raw material.  
· Sulphur is also used in batteries, detergents, fungicides, manufacture of 
fertilizers, gun power, matches and fireworks.  
· Elemental Sulphur is mainly used as a precursor to other chemicals. 
Approximately 85% (1989) is converted to Sulphuric acid -H2SO4. 
Some Sulphur-containing organic compounds: (Cremlyn R. J)  
· Thiols or mercaptans (as they are mercury capturers as chelators) are the Sulphur   
analogs of alcohols; treatment of thiols with base gives thiolate ions. 
· Thioethers are the Sulphur analogs of ethers. 
· Sulfonium ions have three groups attached to a cationic Sulphur 
center. Dimethylsulfoniopropionate (DMSP) is one such compound, important 
in the marine organ ic Sulphur cycle. 
· Sulfoxides and sulfones are thioethers with one and two oxygen atoms attached 
to the Sulphur atom, respectively. The simplest sulfoxide, dimethyl sulfoxide, is 
a common solvent; a common sulfone is sulfolane. 
· Sulfonic acids are used in many detergents. 
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Protein and organic cofactors 
· Sulphur is an essential component of all living cells. It is the seventh or eighth 
most abundant element in the human body by weight. A 70 kg human body 
contains about 140 grams of Sulphur. 
· In plants and animals, the amino acids cysteine and methionine contain most of 
the Sulphur. The element is thus present in all polypeptides, proteins, 
and enzymes that contain these amino acids. In humans, methionine is an essential 
amino acid that must be ingested. However, save for the 
vitamins biotin and thiamine, cysteine and all Sulphur-containing compounds in 
the human body can be synthesized from methionine. 
· Disulfide bonds (S-S bonds) formed between cysteine residues in peptide chains 
are very important in protein assembly and structure. These covalent bonds 
between peptide chains confer extra toughness and rigidity. (Nelson, D. L.) 
· Eggs are high in Sulphur because large amounts of the element are necessary for 
feather formation, and the characteristic odor of rotting eggs is due to hydrogen 
sulfide. The high disulfide bond content of hair and feathers contributes to their 
indigestibility and to their characteristic disagreeable odor when burned. 
· Two of the 13 classical vitamins, biotin and thiamine contain Sulphur, with the 
latter being named for its Sulphur content. Sulphur plays an important part, as a 
carrier of reducing hydrogen and its electrons, for cellular repair of oxidation. 
Health effects of sulphur: 
 All living things need sulphur. It is especially important for humans because it is 
part of the amino acid methionine, which is an absolute dietary requirement for us. The 
amino acid cysteine also contains sulphur. The average person takes in around 900 mg of 
sulphur per day, mainly in the form of protein. 
  Elemental sulphur is not toxic, but many simple sulphur derivates are, such as 
sulphur dioxide (SO2) and hydrogen sulfide. 
  Sulphur can be found commonly in nature as sulphides. During several processes 
Sulphur bonds are added to the environment that are damaging to animals, as well as 
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humans. These damaging sulphur bonds are also shaped in nature during various 
reactions, mostly when substances that are not naturally present have already been added. 
They are unwanted because of their unpleasant smells and are often highly toxic. 
TOXICOLOGICAL EFFECTS 
Acute toxicity: 
Sulphur is known to be of low toxicity, and poses very little if any risk to human 
and animal health (The Agrochemicals Handbook.). Short-term studies show that Sulphur 
is of very low acute oral toxicity and does not irritate the skin. Sulphur also is not a skin 
sensitizer. However, it can cause some eye irritation, dermal toxicity and inhalation 
hazards. 
When taken orally, it has a mild laxative action. It may cause irritation of skin 
and the mucous membranes. Sulphur is considered a skin and eye irritant (Worthing, C. 
R.). Acute exposure inhalation of large amounts of the dust may cause catarrhal 
inflammation of the nasal mucosa which may lead to hyperplasia with abundant nasal 
secretions. Trachiobronchitis is a frequent occurrence, with dyspnea, persistent cough and 
expectoration which may sometimes be streaked with blood. 
Chronic toxicity:  
Chronic exposure to elemental Sulphur at low levels is generally recognized as 
safe. Epidemiological studies show that mine workers exposed to Sulphur dioxide 
throughout their lives often had eye and respiratory disturbances, chronic bronchitis and 
chronic sinus effects. However, no known risks of oncogenic, teratogenic, or reproductive 
effects are associated with the use of Sulphur. Also, Sulphur has been shown to be non-
mutagenic in microorganisms. 
Repeated or prolonged exposure to dust may cause irritation to the mucous 
membranes. Broncho pulmonary disease may occur which, after several years, may be 
complicated by emphysema and bronchiectasis. Early symptoms in Sulphur miners often 
include upper respiratory tract catarrh, with cough and expectoration which is mucoid and 
may even contain granules of Sulphur. Asthma is a frequent complication. The maxillary 
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and frontal sinuses may be affected; involvement is usually bilateral and pansinuitis may 
occur. 
Organ Toxicity 
Pulmonary function may be reduced. Radiological examinations have revealed 
irregular opacities in the lungs and occasionally nodulation has been reported, but not true 
nodular fibrosis. 
Effects of sulphur on the environment: 
 Sulphur can be found in the air in many different forms. It can cause irritations 
of the eyes and the throat with animals, when the uptake takes place through inhalation of 
Sulphur in the gaseous phase. Sulphur is applied in industries widely and emitted to air, 
due to the limited possibilities of destruction of the Sulphur bonds that are applied. 
 Mothers can even carry Sulphur poisoning over to their children through mother 
milk. The damaging effects of Sulphur with animals are mostly brain damage, through 
malfunctioning of the hypothalamus, and damage to the nervous system. 
 Laboratory tests with test animals have indicated that Sulphur can cause serious 
vascular damage in veins of the brains, the heart and the kidneys. These tests have also 
indicated that certain forms of Sulphur can cause foetal damage &congenital effects. 
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3.3 LINGAM  
(Cinnabar, Virmilion) 
Introduction: 
 The mineral substance is red, heavy, brilliant and it is found in native state in 
quick silver mines. Formerly it was mostly imported from China and Batavia. Lingam is 
also known as Inkuligam, Raasam, Karpam, Kadai vanni, Maniraagam etc.  
Vaipu methods of Lingam are detailed in the texts 
 Boga munivar sarakku vaippu - 800  
Matchamuni – 800, etc., 
General properties of Lingam: 
 Lingam is effective in the treatment of diarrhoea, pyrexia, delirium, utricaria, 
dieresis, tuberculosis, unknown insect bites, leprosy, skin diseases. 
 §À¾¢ÍÃï ºó¾¢ ¦ÀÕÅ¢Ã½ ¿£¦Ã¡Î¾ 
 ¸¡¾¸Ê ¸¡ºí ¸ÃôÀ¡ýÒñ - §½¡¾ 
 ×Õ×Ä¢í¸ ºí¸¾Á¡ äÚ¸ðÊ Ôõ§À¡í 
 ÌÕ×Ä¢í¸ ºí¸¾Áò¨¾ì ¦¸¡û. 
                                                                     (Gunapaadam,Thathu-Jeeva vaguppu)                    
 It has the properties of curing the diseases caused by the earth element and cures 
the diseases caused by the water element. 
Purification methods: 
· The crude of Lingam is soaked for one day in mother’s milk and lemon 
juice respectively and it is taken. 
· Lingam is boiled with Lime stone water, Poosani neer (Benincosa hispida), 
Cow’s milk and Lemon juice and is taken as a purified form. 
· Lingam is soaked in Lemon juice and kept in Sunlight (Sooriya pudam). 
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Toxic symptoms of Lingam: 
 Loss of taste, difficulty in eating and drinking water, ulcers in the buccal cavity 
uvula (base of the mouth), inner portion of the tongue, larynx and large intestine, foul 
odour of the mouth, discharge of viscous-whitish saliva, difficult to speak and burning 
sensation are the toxic features of it. 
Antidotes for Lingam:  
 Saathikkai (Myristica fragrans), Vaal milagu (Piper cubeba), Root bark of red 
cotton tree (Gossypium arboreum) and Sugar candy each 4.2 gm are made into a 
decoction and administered twice a day for 48 days. 
Some preparations containing Lingam: 
1. Bala sanjeevi mathirai 
 Dosage  : 1 tablet. 
 Anupaanam  : Notchi juice, Tulasi juice, Surasm of Ginger. 
 Therapeutic uses : 8 types of Maantham 
 *Reference: Siddha vaithiya thirattu, pg no: 7 
 
2. Linga boopathi mathirai 
 Dosage  : Payaralavu. 
 Anupaanam  : suitable anupaanam. 
 *Reference: Siddha vaithiya thirattu, pg no: 30. 
 
3. Shanmuga thala chenduram 
 Dosage  : 1/4 - 1/2 Kundri. 
 Anupaanam  : Honey, Ghee. 
Therapeutic uses : Chronic non-healed ulcers, Gunmam, Thimir kuttam,  
                                   Suram, Araiyappu, Kiranthi. 
 *Reference: Kannusamy parambarai vaithiyam. 
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4. Sorna Pushpa chenduram 
 Dosage  : 1 Kudri. 
 Anupaanam  : Ghee, Honey. 
 Therapeutic uses : Kuttam, Karungkuttam, Megaranam, Pouthiram. 
 *Reference: Kannusamy parambarai vaithiyam. 
 
5. Aanantha vayiravam 
 Dosage  : Milagalvu. 
 Therapeutic uses : Sanni, Gunmam, Kuttam, Moolam. 
 *Reference: Agathiyar chenduram 300. 
 
6. Boopathi kuligai 
 Dosage  : Arisi eadai. 
 Anupaanam  : Mother milk. 
 Therapeutic uses : 13 types of sanni, Thiri thodam 
 *Reference: Agathiyar vaithiya ratna surukkam. 
CINNABAR 
Cinnabar is generally found in a massive, granular or earthy form and is bright 
scarlet to brick-red in color. It occasionally occurs in crystals with a non-metallic 
adamantine luster.  
Cinnabar is the naturally occurring mineral with mercury in combination with 
sulphur, and is red in color so called red mercury sulphide, Zhu Sha or China Red. 
Cinnabar ores are the major source for metallic mercury production. 
General description: 
Category  : Sulphide mineral 
Formula  : mercury (II) sulphide, HgS 
Crystal symmetry : Trigonal Trapezohedral 
H-M symbol  : 3 2 
Space group  : P31 2 1 
Color   : Cochineal-red, towards brownish red and lead-grey. 
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Other forms of cinnabar 
· Hepatic cinnabar is an impure variety from the mines of Idrija in the Carniola 
region of Slovenia, in which the cinnabar is mixed with bituminous and earthy 
matter. 
· Metacinnabarite is a black-colored form of HgS, which crystallizes in the 
cubic form. 
· Synthetic cinnabar is produced by treatment of Hg (II) salts with hydrogen 
sulphide to precipitate black, synthetic metacinnabarite, which is then heated 
in water. This conversion is promoted by the presence of sodium sulphide.  
· Hypercinnabar is crystallised in the hexagonal form. 
Historical uses: 
Cinnabar is insoluble and stable, and cinnabar powder has been used as an 
important ingredient in traditional Chinese medicines and in Indian Ayurvedic medicines 
(Saper RB, Kales SN).  
Cinnabar-gold was used as an alchemical drug of longevity, called  
Makaradhwaja in India (Mahdihassan S.).  
Cinnabar is used to colour paints and as one of red colouring agents used in tattoo 
dyes. Approximately 40 traditional Chinese medicines contain some cinnabar according 
to Pharmacopeia of China and it is the major source of mercury found in traditional 
medicines. 
Disposition of cinnabar: 
The solubility and bioavailability of cinnabar are quite low. The water solubility 
of mercuric chloride is 30–70 g/L, but cinnabar is less than 0.001 g/L at 20°C. 
In the stomach, the lower pH the more cinnabar dissolution as 
Hg2SOH+ formation occurs. In the intestine, sulphur increase cinnabar dissolution as 
mercury-sulphur complexes such as Hg (SH)+, HgS (OH) −, HgS2 (OH) −, and 
HgS3 (OH) − are formed (Zeng KW).  
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Ultrasound can reduce cinnabar particle size and increase cinnabar surface area 
and isoelectric point.  
Absorption 
· Absorption of cinnabar (0.2%) from the gastrointestinal tract is much less than 
mercuric chloride (7–15%), and methyl mercury (>95%). In general, 
bioavailability of cinnabar is 30- to 60- fold less than mercuric chloride  
(Schoof RA).  
· Nonetheless, both crude cinnabar and synthetic mercury sulphide have very low 
oral bioavailability and are poorly absorbed from the gastrointestinal tract as 
compared to mercuric chloride and methyl mercury, but are better than liquid 
elementary mercury (less than 0.01%). Mercury vapour is readily absorbed (80%) 
through diffusion in the lungs. When cinnabar is heated, mercury vapour is 
released, and is easily absorbed to produce local and systemic toxicity.  
· This is why in Pharmacopeia of China (Pharmacopoeia of China), heating 
cinnabar is restricted. Cinnabar is not used in injectable preparations. Little is 
known about cinnabar absorption via the skin, or from parenteral administration. 
Distribution and biotransformation 
· The distribution of mercury from absorbed cinnabar basically follows the 
distribution pattern for inorganic mercurials. The highest concentration of mercury 
is found in kidney, a major target of inorganic mercury exposure. (Sin YM).  
· Inorganic mercury salts do not readily pass blood-brain barrier or placenta. 
However, a small portion of absorbed inorganic mercury can be reduced in tissues 
and exhaled as mercury vapour.  
· A significant portion of mercury vapour crosses the blood-brain barrier and 
placenta before it is re-oxidized to divalent inorganic mercury by tissue and 
erythrocyte catalase. Oral cinnabar or synthetic mercury sulphide administration 
results in brain distribution (about 10% of renal accumulation), mainly to the 
cerebral cortex and cerebellum.  
· In the Chinese literature, it is assumed that cinnabar could be converted to methyl 
mercury in the intestine under anaerobic conditions at pH 7 (Liang AH). 
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However, no evidence is available to support this assumption. Intestinal bacteria 
can convert methyl mercury to inorganic mercury. 
· To better understand toxicokinetics of cinnabar is very important for appropriate 
safety assessment of mineral cinnabar used in traditional medicines. 
TOXICITY PROFILE: 
· Cinnabar-containing traditional medicines are generally relatively non-toxic at 
therapeutic doses. The correct preparation methods, appropriate doses, disease 
status, age and drug combinations are important factors impacting cinnabar 
toxicity (Liang AH).  
· In general, the adverse effects at therapeutic doses of cinnabar-containing 
traditional medicines are rare and are largely tolerable and reversible. The 
cinnabar poisoning cases are associated with overdose, long-term uses, and 
improper processing such as heating, decocting, fumigating, or in combination 
with other drugs (Liang AH).  
· The long-term use of cinnabar-containing traditional medicines could result in 
renal dysfunction due to accumulation of mercury in the kidney. Blurred vision 
due to accumulation of mercury in brain is possible, gastrointestinal symptoms 
also often occur following long-term administration. Skin allergic reaction may 
occur when cinnabar is used in tattoo dyes (Bagley MP). 
· Inhalation of mercury vapour produces acute corrosive bronchitis and interstitial 
pneumonitis and, if not fatal, may be associated with central nervous system 
effects such as tremor or increased excitability. With chronic exposure to mercury 
vapour, the major effects are on the central nervous system. The triad of tremors, 
gingivitis and erethism (memory loss, increased excitability, insomnia, depression 
and shyness) has been recognized historically as the major manifestation of 
mercury poisoning from inhalation of mercury vapour. Sporadic instances of 
proteinuria and even nephrotic syndrome may occur in persons with exposure to 
mercury vapour, particularly with chronic occupational exposure (ATSDR). 
· Kidney is the major target organ for inorganic mercury in humans and in 
experimental animals. Although a high dose of mercuric chloride is directly toxic 
to renal tubular cells, chronic low-dose exposure to mercuric salts may induce an 
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immunologic glomerular disease. Exposed persons may develop proteinuria that is 
reversible after workers are removed from exposure.  
· Acrodynia has occurred in children chronically exposed to inorganic mercury 
compounds in teething powder and diaper disinfectants, as well as to 
organomercurials. Acordynia is characterized by pink hands and feet (also called 
Pink Disease). These subjects are photophobic and suffer from joint pains 
(Clarkson TW).  
· The major human health effect from exposure to methyl mercury is neurotoxicity. 
Clinical manifestations of neurotoxicity include paresthesia (a numbness and 
tingling sensation around the mouth, lips) and ataxia, manifested as a clumsy, 
stumbling gait, difficulty in swallowing and articulating words. Other signs 
include neurasthenia (a generalized sensation of weakness), vision and hearing 
loss, and spasticity and tremor. There may finally progress to coma and death.  
Children are sensitive: 
§ Early life stages are particularly vulnerable to mercury intoxication. 
§ Cinnabar-containing Chinese medicines are used in pediatrics, mainly for their 
sedative and hypnotic effects.  
§ Toxicity has been reported from inappropriate use of cinnabar and cinnabar-
containing medicines in infants and preschool children (Kang-Yum E). Thus, 
caution should be taken when cinnabar-containing Chinese medicines are used for 
children, as children are susceptible to mercury toxicity. 
Treatment: 
· Therapy for mercury poisoning should be directed toward lowering the 
concentration of mercury at the critical organ or site of injury.  
· In acute renal failure, hemodialysis may be the first measure, along with 
administration of chelating agents for mercury, such as dimercaprol (BAL), 2, 3-
dimercaptosuccinic acid (DMSA, succimer), EDTA (calcium disodium, edentate 
calcium disodium), or D-penicillamine (NAP).  
· Succimer (DMSA) is a FDA-approved pediatric use in the treating mercury 
poisoning. 
 
30 
 
3.4 THALAGAM 
(Yellow arsenic, Arsenic trisulphide) 
Introduction: 
 Thalagam is called in various names such as Arithaaram, Kothandam, Peethagi, 
Aalambi, Maaldevi, Ponvarni, Maanjal varni. It is as such available alone in India in 
small quantities. It is also available in combination with iron. Though most of the western 
countries do not use this medicine for internal administration, it is used for internal 
administration in small quantities in India. Depending upon the colour, appearance and 
properties it has been classified into four types. 
1. Sivappu Arithaaram - treatment of fever with chills, pricking pain and leprosy. 
2. Madal Arithaaram - treatment of asthma, kapham, cough and non healing 
ulcers. 
3. Pon Arithaaram - treatment of high chronic fever, poisonous insect bites. 
4. Karattu Thalagam – treatment of cough and eight types of ulcers(gunmam). 
General properties of Thaalagam: 
¾¡Ç¸ò¾¢ý §ÀÕ¨Ãì¸ò ¾¡Ö¸×û §¿¡öÌð¼õ 
¿£Çì ÌÇ¢÷¸¡öîºø ¿£Î¸Àõ - ¿¡Ç¸í¦¸¡û 
Ð‰¼ô ÀÈí¸¢ôÒñ ÝÆØ¸ñ Áñ¨¼§¿¡ö 
¸¢ð¼ô ÀÎÀÁ¡ ¸¢ÇòÐ. 
                                                   (Gunapadam, Thathu –Jeeva vaguppu) 
 
Thaalgam is effective in the treatment of skin diseases, diseases of head and 
tongue, fever with chills, kapha diseases, veneral(parangi pun) focus ulcer in the urethra 
etc. 
 
Purification methods: 
1. 35 gm of Thalagam is bundled in a cloth and soaked separately in cow’s urine, 
rice water fermentation, lime water, pumpkin juice, cow’s milk and decoction 
of peepul tree(Ficus religiosa) and subjected to Thulayanthiram method. 
1.3litres of liquid material is taken in each. 
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2. 35 gm of Thalagam is burried within lime stone. Palm toddy is poured on the 
lime stone for 10 times to get purified. Then the Thalagam is washedout and 
dried. 
3. Small pieces of the material is bundled in a double layer cloth and is kept 
immersed in cow’s urine and heated for 3 days. The same process is repeated 
with the rice cleaned water, vinegar (Kaddi), individually to get purified form. 
Toxic symptoms of Thalagam: 
 An improper purification or administration will cause toxic effect.  
The signs and symptoms  are burning pain of the stomach, hoarseness of voice, 
nasal bleeding, bleeding from the nail buds, loss of appetite and loss of smell, indigestion, 
itching over the body, redness in the tip of the hairs, lower abdominal swelling and 
throbbing pain in the lumbar regions.  
Antidotes for Thalagam:  
§¾ÕÅ¡ö ¾¡Ç¸ò¨¾ ¾¢ý§È¡÷ìÌ ¿£Ä¢Â¾ý 
§ÅÕ¼§É Â¡Å¢Ãõâ ¦ÅðÊ§Å÷ - º£Ã¸Óõ 
Á¡¾¨ÇÅ¢ò §¾¡Î¦¾ýÉõ ÅíÌÕõ¨À ¸¡º¢É¢§Å÷ 
¾£¾¸ø ¿üÌÊ¿£÷ ¦ºö.                                        (Agathiyar vida pirathi vida thirattu)     
 
¦¸¡Ê§ÅÄ¢ Â¡Å¢¨Ã§Å÷ ¦¸¡îº¢ Á¢ÇÌí 
¸¼Öô À¢¨Å¸ÄóÐ ¸¡öîº¢ - Ô¼Ä¢Ûì 
ÜÚ¦ºö¾ ¾¡Ç¸ò¾¡ ÖüÈÅ¢¼ ¿£í¸¢Â¢Õ 
ÜÚ¦ºöÐ ¿ýÈ¡ö ÌÊ.                                             (Karuvur Devar Thandagam) 
1. Each 10 grams of Indigofera tinctoria (Avuri) root bark, cassia auriculata 
(Avarai) flowers, Andropogan muricatus root, (Vettiver), Cuminum Cyminum 
(Seeragam) seeds, Punica granatum (Mathulai) seeds,tender leaves of Cocos 
nucifera (Kurumbai) -  and Cichorium intybus(Kasini keerai) root are boiled 
with water and the decoction is administered. This will neutralize the toxic 
effects of yellow orpiment. 
2. Each 10 grams of root bark of Plumbago zeylanica (Chithromoolam) and  
pepper is boiled in water, made into decoction and 5 grams of Sodium 
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Chloride is well dissolved and administered daily for 20, 30, or 40 days 
depending upon the severity of the toxic effects. 
Some preparations containing Thalagam: 
Thalaga parpam 
 Dosage  : 488mg. 
 Anupaanam  : honey. 
 Therapeutic uses :Ilaippu, Enburukki, Pramiyangal. 
 *Reference: Siddha Maruthuva Chinthamani, pg no: 114.  
 
Thalaga karuppu 
 Dosage  : 1-2 ulunthu. 
 Anupaanam  : honey, ghee, thalisathi choornam. 
 Therapeutic uses :Kaasam, Suvasa kaasam, Suram. 
 *Reference: Gunapaadam – Thathu jeeva vaguppu,  pg no:339. 
 
Thalaga mathirai  
 Dosage  : 1-2, twice a day. 
 Therapeutic uses : All types of suram. 
 *Reference: Anuboga vaithiya bramma ragasiyam, pg no: 94. 
 
Arithaara kuligai 
 Therapeutic uses : Kan kasam used externally with honey. 
 *Reference: Marunthu seimuraigal, pg no: 104. 
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YELLOW ORPIMENT 
Introduction:   
  Arsenic trisulphide is a naturally occurring form of trivalent arsenic. Orpiment 
is one of the major arsenic containing mineral. It is also manufactured from the reaction 
of arsenic trioxide with sulphur and is available commercially. Arsenic trisulphide is 
insoluble in water and so poorly absorbed. If therefore represents much less of an acute 
toxic hazard than soluble arsenic compounds. 
Synonyms 
 Kings gold, Arsenous sulphide, Arsenic sequisulphide, Diarsenic trisulphide, 
Arsenic sulphide, Arsenious sulphide.                     
Chemical name and formula 
Name  : Arsenic tri sulphide 
Formula : As2 S3 
Physical properties 
Colour        :    Yellow-orange                            
Molecular weight : 246.04g/mol  
Melting point  : 300ºc 
Density  : 4.25gm/cm3 
Boiling point   : 707ºc 
Origin and History: 
  It is an historical pigment. It has been identified on ancient Egyptian objects and 
paintings from the thirty-first to the sixth century B.C. It is mentioned in Greek and 
Roman literary sources. The Hellenistic Leyden papyrus described its use for late 
Egyptian painting, as does the Mappae Clavicula for early mediaeval painting. The 
pigment has been described in various other medieval manuscripts dating from the 12th to 
the 15th centuries. 
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Source: 
            Orpiment is a rare mineral that usually forms with realgar. In fact the two 
minerals are almost always together. Crystals of orpiment are extremely rare as it usually 
forms masses and crusts. The masses are sometimes transparent to a degree and have a 
gemmy quality to them. The yellow color is special to orpiment and can be confused only 
with a few other minerals. Orpiment is derived from the latin auripigmentum, or "golden 
pigment." The largest quantities of orpiment were found in Turkish Kurdistan (Julamerk), 
and in the Russian republic Georgia.  
The orpiment in Italian painting often came from the fumaroles of mount 
Vesuvius and from the Campi Flegrei in Tuscany. Since the later Middle Ages the 
pigment was also artificially made. This pigment would most likely be the result of 
sublimation of arsenic, or arsenic oxide and orpiment with or without the addition of 
sulfur. Notable occurrences of orpiment are found today in Kyrgyzstan; Romania; Peru; 
Japan; Utah, USA; and Australia. 
Preparation 
   Arsenic trisulfide is made when an arsenic compound like arsenic trichloride 
reacts with hydrogen sulfide. It is also made when arsenic and sulfur are heated together. 
Uses 
 As2S3 and As4S4 have been investigated as treatments for acute promyelocytic 
leukemia (APL) (D.-P. Lu, et al).  It was looked at for treating cancer and also used in 
cosmetics.   
TOXICOKINETICS 
Absorption: 
               Arsenic trisulphide is poorly absorbed after ingestion .The efficiency of 
absorption is dependent on particle size; fine powders are better absorbed than larger 
particles. 
               Following inhalation irrespirable particles are trapped in the upper airways and 
deposited in the gastrointestinal tract by mucociliary clearance. 
               Direct evidence of transcutaneous arsenical absorption in man is scarce.  
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Distribution: 
 Absorbed arsenic is distributed to all body tissues. High concentrations would 
be expected in keratin-rich tissues such as hair, skin and nails due to sulphydryl group 
binding. Trivalent arsenic is methylated in the liver to methylarsonic acid and a 
dimethylarsinic acid Short-term study on humans indicate that daily intake in excess of 
0.5 mg progressively, but not completely, saturates the capacity to methylate inorganic 
arsenic. 
Excretion: 
 The half-life of arsenic in blood is about 60 hours with rapid renal excretion 
predominantly as mono- and dimethyl- derivatives. Small amounts excreated in faeces, 
suggesting minor biliary clearance. 
MECHANISM OF TOXICITY 
 The principle mechanism of arsenic intoxication is disruption of thiol proteins. 
For example, arsenic inactivates pyruvate dehydrogenase by complexing with the 
sulphydryl groups of a lipoic acid moiety (6, 8-dithiooctanoic acid) of the enzyme. 
 Enhanced cellular destruction of damaged thiol proteins may produce toxic 
oxygen radicals. 
 Arsenic-induced reduced lymphocyte proliferation and impaired macrophage 
function also have been described. 
ACUTE TOXICITY 
 Systemic toxicity may follow arsenic trisulphide ingestion, inhalation or topical 
exposure. 
 
Topical 
 Irritant to skin and mucous membranes. Systemic arsenic poisoning may occur 
after substantial exposure. 
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Ingestion 
 Rapid onset (within 1-2 hours) of burning of the mouth and throat,  
hypersalivation, dysphagia, nausea, vomiting, abdominal pain and diarrhoea. In severe 
cases gastrointestinal haemorrhage, cardiovascular collapse, renal failure, seizures, 
encephalopathy and rhabdomyolysis may occur. 
Other symptoms:  
· Facial and peripheral oedema, ventricular arrhythmias.  
· Muscle cramps. 
· Investigations may show anaemia, leucopenia, thrombocytopenia or evidence of 
intravascular haemolysis. 
· Death may occur from cardio respiratory or hepato renal failure. The adult 
respiratory distress syndrome (ARDS) has been reported. 
· Survivors of severe poisoning may develop a peripheral neuropathy and skin 
lesions typical of chronic arsenic poisoning. 
Inhalation 
   Rhinitis, pharyngitis, laryngitis and tracheobronchitis may occur. In severe 
poisoning tracheal and bronchial haemorrhage may occur.  
CHRONIC TOXICITY 
 May occur following ingestion, inhalation or topical exposure. Features include 
weakness, lethargy gastrointestinal upset, dermal manifestations (hyperkeratosis and 
"raindrop" pigmentation of the skin), a peripheral (motor and sensory) neuropathy and 
psychological impairment. And also Peripheral vascular disease (cold sensitivity 
progressing to ulceration and gangrene), renal tubular or cortical damage and 
haematological abnormalities (notably pancytopenia) are reported. 
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MANAGEMENT 
Ingestion  
Very small ingestions: 
1. Gastrointestinal decontamination is unnecessary. 
2. Symptomatic treatment. 
 
Substantial ingestions: 
· Gastric lavage should be considered only if the patient present within one 
 hour. 
· Supportive measures are paramount. Intensive resuscitation may be required.   
· Ensure adequate fluid replacement and close observation of vital signs including 
cardiac monitoring. 
· Diarrhoea can be controlled with loperamide. 
· Monitor blood urea, creatinine, electrolytes, liver function and full blood count. 
· Collect blood and urine for arsenic concentration measurements. 
· Isoprenaline is effective with phenytoin, lignocaine or propranolol as alternatives. 
 
Antidotes - chelation therapy with either dimercaprol, DMSA or DMPS. 
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3.5 MANOSILAI 
(Arsenic disulphidum, Red orpiment) 
Introduction: 
 Manosilai is two types – one is piravi sarakku and the other one is vaippu sarakku. 
Vaippu sarakku is obtained by adding five parts of white arsenic with three parts of 
ganthagam. This is effective in skin leprosy, fever with chills, eye diseases, urinary tract 
infections, kapha diseases. 
¦¸¡ÊÂ Ì‰¼õ ¸¡öîºø ¿Îì¸Äƒ ¸øÄ¢Â¢¨Ãô 
Òîº¢Äó¾¢ô §ÀºÚÁ §É¡º¢¨ÄìÌô §ÀÍ. 
                                                           (Gunapadam, Thathu-Jeeva vaguppu) 
It is also useful in the treatment of ajakallika (a type of boil occurring in children). 
Purification methods: 
· Manosilai is triturated with any one of the following – Ginger juice, 
Lemon juice, Cow’s butter milk for three hours. Then it is dried to get 
purified form. 
· The raw material is made into small pieces and kept soaked in 175 gm of 
fermented buttermilk in a clay vessel. It is kept in sunlight and mixed 
frequently. 
· Manosilai is powdered and triturated with filtered water of lime and with 
kollu(Macrotyloma uniflorum) saaru. 
Medicinal Uses: 
 Manosilai is mostly used not as such alone but in combination with other 
medicines as pills and oil. The oil is effective in the treatment of pauthiram(fistula) when 
applied topically. The pill is effective in the treatment of fever with chills when given 
orally. 
 It is mixed with ash of Nayuruvi (Achyranthes aspera) and applied externally for 
venkuttam. 
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Some preparations with Manosilai: 
Medicines for eye diseases in Sarabaenthirar nayana rogha sikichai 
1. Santhirodhaya Kuzhambu 
2. Sarasaanjanam 
3. Logaanjanam 
 Manosilai containing drugs in Pulipani Marunthugal 
1. Rathinathi kuligai 
2. Navarasa mezhugu 
In Agathiyar vaithiya surukkam, 
1. Kalakandamega naarayana chenduram 
2. Poorna chanthirothayam 
Manosilai drugs in Vida vaithiya aarudam  
1. Thirugu thylum 
2. Vida marunthugal 
 
RED ORPIMENT 
Introduction: 
 Arsenic disulphide is a naturally occurring form of arsenic and is found as 
realgar, one of the major arsenic containing mineral. Arsenic disulphide is insoluble in 
water and so poorly absorbed. It therefore represents a much less acute toxic hazard than 
soluble arsenic compounds. 
Synonyms:   
 Red arsenic sulphide, Arsenic sulfide, Arsenic sulphide, Arsenic disulphide, Red 
orpiment, Ruby arsenic, Realgar. 
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Chemical name and formula: 
Name        : Arsenic di sulphide 
Molecular formula:  As2S4 
Physical properties: 
 Colour  : Red-brown    
 Melting point :  320º C  
 Boiling point :  565º C  
 Solubility  :  Insoluble in water  
 Molecular weight : 213.97                                   
 
Preparation 
It is artificially prepared by fusing arsenious acid 5 parts and sulphur 3 parts. 
Uses 
 Used in Leather industry, depilatory agent, paint pigment, shoe manufacture, 
pyrotechnics, rodenticide,( Factsheet for Realgar) colouring agent in fireworks. 
 As2S3 and As4S4 have been investigated as treatments for acute promyelocytic 
leukemia (APL).( D.-P. Lu,et,al )  
Traditional uses 
· Realgar, orpiment, and arsenopyrite provide nearly all the world's supply 
of arsenic as a byproduct of smelting concentrates derived from these ores. 
· Realgar is poisonous. The ancient Greeks, who called it "sandaracha", knew that it 
was poisonous. It was used to poison rats in medieval Spain and in 16th century 
England.(In French) 
· It is still sometimes used to kill weeds, insects, and rodents, even though more 
effective arsenic-based agents are available. 
· It was, along with orpiment, a significant item of trade in the ancient Roman 
Empire and was used as a red paint pigment (Boston)  and a medicine. 
· Other traditional uses include manufacturing shot, printing and dyeing calico. 
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· It is purified by being rubbed with the juice of lemon or of Ginger. It is used as an 
alternative, febrifuge, and tonic, given in fever, cough, and asthma. In skin 
diseases it is used externally and locally it is applied to fistulous sores. 
TOXICOKINETICS 
 Absorption 
   Arsenic disulphide is poorly absorbed after ingestion. The efficiency of 
absorption is dependent on particle size. Following inhalation irrespirable particles are 
trapped in the upper airways and deposited in the gastrointestinal tract by mucociliary 
clearance. Direct evidence of transcutaneous arsenical absorption in man is scarce.  
Distribution 
 Absorbed arsenic is distributed to all body tissues. High concentrations would 
be expected in keratin-rich tissues such as hair, skin and nails due to sulphydryl group 
binding. Trivalent arsenic is methylated in the liver to methylarsonic acid and dimethyl 
arsenic acid Short-term studies on humans indicate that daily intake in excess of 0.5 mg 
progressively, but not completely, saturate the capacity to methylate inorganic arsenic. 
Excretion 
     The half-life of arsenic in blood is about 60 hours with rapid renal excretion 
predominantly as mono- and dimethyl- derivatives.   
Toxicity 
 Arsenic disulphide poisoning is rare. Exposure may occur via ingestion of 
herbal remedies or in industry.   
ACUTE TOXICITY: 
Dermal exposure:     
 Erythema, burning and itching, eczematous eruptions and folliculitis are typical. 
 Ocular exposure: 
 Arsenic disulphide is an eye irritant. Most injuries result from exposure to dusts, 
causing conjunctivitis, lacrimation, photophobia. 
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Ingestion: 
  Insoluble, poorly absorbed compounds such as arsenic disulphide represent less 
of a toxic hazard than water soluble arsenic species. However, substantial ingestions may 
produce serious systemic toxicity. 
 Gastrointestinal toxicity: 
  Nausea, vomiting, abdominal pain and diarrhoea are likely after substantial 
arsenic disulphide ingestion. Other features include burning of the mouth and throat with 
dysphagia and hyper salivation. Gastrointestinal haemorrhage may lead to cardiovascular 
collapse. 
Nephrotoxicity: 
 Hypotension or rhabdomyolysis following substantial arsenic disulphide 
ingestion may precipitate renal failure. 
Cardiovascular toxicity: 
  Tachycardia is typical in cases of arsenic intoxication and is contributed to by 
anxiety, intravascular fluid depletion and possibly a direct cardio toxic effect. 
Neurotoxicity: 
 Acute substantial arsenical ingestion has caused muscle cramps, hearing deficit, 
encephalopathy and seizures. 
Haemotoxicity: 
 In moderate or severe arsenic poisoning investigations typically shows anaemia, 
leucopenia or pancytopenia 
Multi-organ toxicity: 
 Severe acute arsenic poisoning may result in death from cardio respiratory or 
hepato renal failure. 
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CHRONIC TOXICITY 
 May occur following ingestion, inhalation or topical exposure. Features include 
weakness, lethargy gastrointestinal upset, dermal manifestations (hyperkeratosis and 
"raindrop" pigmentation of the skin), a peripheral (motor and sensory) neuropathy and 
psychological impairment. And also peripheral vascular disease (cold sensitivity 
progressing to ulceration and gangrene), renal tubular or cortical damage and 
haematological abnormalities (notably pancytopenia) are reported. 
MANAGEMENT 
· Gastrointestinal decontamination is unnecessary. 
· Symptomatic treatment. 
· Supportive measures are paramount. Intensive resuscitation may be  required. 
Ensure adequate fluid replacement and close observation of vital signs 
including cardiac monitoring. 
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3.6 VELLAI PAADANAM 
(White arsenic) 
Introduction: 
 This is obtained from nature in the land. It is mostly available in the combination 
with other metals such as sulphur, iron, copper etc. When used in small doses it stimulates 
appetite; improves body strength; reduces fever. It also stimulates the heart, lungs, bowels 
and reproductive organs. 
General properties of Vellai Paadanam: 
¦Åû¨ÇôÀ¡ ¼¡½õ Å¢¼í¸Ê¾£ Õõâºì 
¦¸¡û¨Çî ÍÃò§¾¡„í §¸¡Ãºó¿¢ - ¦¾¡û¨ÇÔÚ 
¿¡º¢ôÒñ Å¡öôÒñ ¿¨É¸¢Ãó¾¢ §À¡Óñ½ 
¬º¢ìÌí ÌõÀÓ¨Ä ¬ö. 
     (Gunapaadam, Thathu-Jeeva vaguppu) 
 
It has been found to be effective in the treatment of epidemic fever, poisonous 
bite, delirium, infections, ulcers of the nose and mouth and venereal ulcers. Further, this 
is also effective in filarial fever, skin diseases, etc. 
 
Purification methods: 
1. Vellai Paadanam (35 gm) is powdered and triturated with lemon juice. It is 
made into small cakes and dried. This process is repeated for seven times. 
2. Vellai Paadanam is buried within the limestone and processed with the 
palm toddy for seven times to get purified. 
3. Vellai Paadanam is subjected to churukku by adding avuri(Indigafera 
tinctoria) juice and white variety of erukku (Calotropis gigantean)juice for 
nine hours separately. 
4. Strebulus asper pit oil (kutti palaa kuzhi thailam) is added gradually to the 
heated Vellai Paadanam to get purified form. 
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Toxic symptoms of Vellai Paadanam: 
 White arsenic is quite toxic when used even in slightly excess doses. When used 
in high doses it may cause death. Even when used in small doses for long period, it may 
produce toxic signs and symptoms. 
Acute Poisoning: 
 Signs and symptoms are blisters, pain in the fingers of hands and legs, swelling of 
the face, ulcer of the upper lip, bad odour in the vomiting, pain in the throat, tasteless in 
the mouth, burning sensation in the stomach, bleeding diarrhoea and vomiting, excessive 
sweating, convulsion, impairment of memory, etc. 
Chronic Poisoning: 
 The signs and symptoms of chronic poisoning are pruritis, eczematic lesions, 
kaamalai(liver damage causing jaundice), indigestion. 
Antidotes for Vellai Paadanam:  
· Four grams - in each of Cardamom (Elakkai) and Mukia Scaberilla 
(Musumusukai) root is boiled in water and of white sugar and Alum (Padikaaram) 
is mixed with the above decoction and is given twice for 40 days both morning 
and evening in empty stomach. 
· Indigofera tinctoria (Avuri) root and black pepper is well boiled and the decoction 
is given. 
· Indigofera tinctoria (Avuri) root is made into karkam and is given as Kottai 
pakalavu for two times a day. 
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ARSENIC TRIOXIDE 
Introduction: 
Arsenic trioxide is a white or transparent solid in the form of glassy, shapeless 
lumps or a crystalline powder that resembles sugar. It has no odour or taste. It forms 
readily when elemental metallic arsenic is heated to high temperatures or burned. When 
arsenic trioxide is burned, it releases toxic fumes and arsine gas which is highly toxic. 
General Description: 
Molecular formula : As2O3 
Molar mass  : 197.841 g/mol 
Appearance  : White solid 
Density  : 3.74 g/cm3 
Melting point    : 312.2 °C, 585 K, 594 °F 
Boiling point  : 465 °C, 738 K, 869 °F 
Solubility in water : 20g/L(25 °C) 
Solubility : soluble in dilute acids and alkalies, practically insoluble in     
organic solvents (Patnaik, P.)  
Natural occurrence: 
Two minerals are known to possess the As2O3 chemical formula: 
arsenolite(regular) and claudetite (monoclinic). Both are relatively rare secondary 
minerals found in oxidation zones of As-rich ore deposits Traces of arsenic may naturally 
contaminate drinking water wells.  
Medical applications: 
· Despite the well known toxicity of arsenic, arsenic trioxide has long been of 
biomedical interest, dating to traditional medicines, where it is known as 
PiShuang in Chinese medicine and is still used to treat cancer and other 
conditions, ( Gielen, M.; Tiekink, E. R.) and to homeopathy, where it is called 
arsenicum album.  
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· Some discredited patent medicines, e.g., Fowler's solution, contained derivatives 
of arsenic oxide. 
·  Arsenic trioxide under the trade name Trisenox is a chemotheraputic agent of 
idiopathic function used to treat leukemia that is unresponsive to "first line" 
agents. It is suspected that arsenic trioxide induces cancer cells to undergo 
apoptosis.  
· Due to the toxic nature of arsenic, this drug carries significant risks. Use as a 
cytostatic in the treatment of refractory promyelocytic (M3) subtype of acute 
myeloid leukemia (Soignet, S. L.).  
· The combination therapy of arsenic trioxide and all-trans retinoic acid (ATRA) 
has been approved by the U.S. Food and Drug Administration (FDA) for 
treatment of certain leukemias. University of Hong Kong developed a liquid form 
of arsenic trioxide that can be administered orally.  
· Arsenic trioxide also appears to be a promising therapeutic agent for autoimmune 
diseases. ( Bobé, P.)  
· The enzyme thioredoxin reductase has recently been identified as a target for 
arsenic trioxide. (Lu, J.; Chew, E. H.)  
· Arsenic trioxide in combination with ascorbic acid and buthionine sulfoxide 
decrease intracellular glutathione to a greater extent, and render malignant cells 
more sensitive to apoptosis.  
· Arsenic trioxide induced apoptosis was not enhanced by ascorbic acid in normal 
cells, suggesting that this combination may be selectively toxic to some malignant 
cells.  
Toxicology: 
Arsenic trioxide is readily absorbed by the digestive system: toxic effects are also 
well known upon inhalation or upon skin contact. Elimination is rapid at first (half-life of 
1–2 days), by methylation to monomethylarsonic acid and dimethylarsonic acid, and 
excretion in the urine, but a certain amount (30–40% in the case of repeated exposure) is 
incorporated into the bones, muscles, skin, hair and nails (all tissues rich in keratin) and 
eliminated over a period of weeks or months. 
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Acute arsenic poisoning: 
§ The first symptoms of acute arsenic poisoning by ingestion are digestive 
problems: vomiting, abdominal pains, diarrhea often accompanied by bleeding.  
§ Sub-lethal doses can lead to convulsions, cardiovascular problems, inflammation 
of the liver and kidneys and abnormalities in the coagulation of the blood. These 
are followed by the appearance of characteristic white lines (Mees stripes) on the 
nails and by hair loss.  
§ Lower doses lead to liver and kidney problems and to changes in the pigmentation 
of the skin. Even dilute solutions of arsenic trioxide are dangerous on contact with 
the eyes. The poisonous properties are legendary and the subject of an extensive 
literature. (Emsley, J.)  
Chronic arsenic poisoning: 
· Chronic arsenic poisoning is known as arsenicosis. This disorder affects workers 
in smelters, in populations whose drinking water contains high levels of arsenic 
(0.3–0.4 ppm), and in patients treated for long periods with arsenic-based 
pharmaceuticals.  
· Long-term ingestion of arsenic trioxide either in drinking water or as a medical 
treatment can lead to skin cancer.  
· In Austria, there lived the so-called "arsenic eaters of Styria", who ingested doses 
far beyond the lethal dose of arsenic trioxide without any apparent harm. Arsenic 
is thought to enable strenuous work at high altitudes, e.g. in the Alps. (Whorton, J. 
C.)  
· Reproductive and Developmental Effects  - Arsenic ions released from arsenic 
trioxide within the body can cross the placenta and affect the developing fetus 
arsenic is also excreted in breast milk. Experimental animal studies support an 
association between high ingested arsenic dose and fetal toxicity. 
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Treatment: 
· There is no specific antidote for arsenic trioxide. 
· Symptematic treatment 
· Prehospital treatment consists of supportive care and gastric decontamination. 
· Chelation therapy is strongly recommended. 
· In cases of ingestion, emesis should not be induced.  
· Aggressive decontamination with gastric lavage is recommended within 1 hour of 
ingestion of a life-threatening amount of poison. 
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3.7 POORAM 
(Rasa karpooram, Hydrargyrum subchloride, Calomel) 
Introduction: 
 Although the Pooram does not find a place in the list of sixty four paadanam it is 
considered as one among them by the medical practitioners. It is prepared by the 
combination of Rasam and Salt. It has  laxative, tonic, antiseptic and diuretic properties. It 
induces biliary secretion. 
General properties of Pooram: 
ºº¢ÅýÉ ¸Õôâ Ãò¾¢ø º¡¾¢ò¾ ¸ÂïÍ Å¡ºõ 
Àº¢¸Ä¢  ¾¡À §º¡Àõ À×ò¾¢Ãõ À¢Ç¨Å Ì‰¼õ 
Åº¢¾Õ ¸¢Ã¡½¢ §Â¡Î ÅÇÃ¾¢ º¡Ã §Á¸õ 
þº¢¾Õ Á¢º¢× Ý¨Ä Â¢¨ÅÀÄ §Ã¡¸õ §À¡§Á. 
                                                    (Gunapaadam, Thathu – Jeeva vaguppu) 
 
When the Pooram is taken along with jaggery for seven days, it cures various 
types of excruciating  pains, throbbing pain in the lumbar region, burning sensation, ulcer 
due to disorders of  vatham, manjal kaamalai(Jaundice), pyrexia, chronic ulcers, venereal 
diseases, indigestion, vomiting, diarrhoea, worm infestation, rheumatism, itching, 
constipation, scabies etc. 
Purification methods: 
1. Pooram(35gm) is processed by surukku method  with mother’s milk for three 
hours and with garlic thylam for nine hours. It is taken out as purified. 
2. Before adding the Pooram in lekeyams, it is subjected to surukku process with 
the juice of musumusukkai(Mukia maderaspatana). 
 Pooram does not dissolve in water rapidly. If it is consumed in large quantity, it 
manifests poisonous effects. 
 The signs and symptoms of Calomel poisoning are multiple red boils may appear 
on the face, acne formation, ulcers in the chest, mouth and tongue, diarrhoea and 
dysentry, scrotal swelling and ulcer in the uvula. 
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Antidote for poisoning: 
  À¸ÕÅ¡ö âÃò¨¾ô À¡íÌ¼ýÈ¢ý §È¡÷¸ð 
¸¢¸Ä¡¢Â Ìø¨ÄÂ¢ýº¡ È£¸  - ¾¸×¨¼Â 
²Ãñ¼ ¦¿öÂ¡ ¦ÁÆ¢Ä×¡¢ §ÅÃ¡Ìõ 
º£÷¦¸¡ñ¼ À¡¸Ä¢¨Ä §¾÷.                                                         
                                                               (Agathiyar vida pirathi vida thirattu) 
1. Ocimum sanctum (Thulasi) leaf juice, or Castor oil or Momordica charantia 
(Kombu Pagal) leaf juice, twice a day till the poisonous effects are neutralized. 
Again  a small spoon of Castor oil may be given when it is given second time. 
2.  Indigofera tinctoria (Avuri) root bark is ground in hot water and is given in the 
quantity of a Sundai (Solanum pubescens) twice daily. 
3. To reduce the poisonous effect, the powder of Alum (Seenakkaram) mixed in the 
tender coconut water is given. The kernel of the tender coconut is also given. 
4. Nilappanai kizhangu kudineer: 
Black musali tubers (Curculigo orchides) 
  Indian penny wort root (Centella asiatica root) 
  Root of sessile plant (Alternanthera sessiles) 
  Beetle killer (Clerodendrum serratum –Kandu paarangi) 
 All the above ingredients are mixed and boiled to make a decoction. This 
decoction is used twice a day for two or three weeks with suitable diet restrictions. 
Some preparations containing Pooram: 
1. Vaalai sancheevi mathirai 
 Dosage  : Uluthalavu. 
 Therapeutic uses : Vatha roagam, Maantham, Suram. 
 Reference: Siro rathina vaithiya poosanam, pg no: 49. 
 
2. Mahasathuvaathi kuligai 
 Dosage  : Sundai alavu. 
 Therapeutic uses : Gunmam, Peligai, Kudal vayu. 
 Reference: Agathiyar vaithiya vallathi, pg no: 35. 
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3. Sootha vallathi urundai 
 Dosage  : Milagalavu. 
 Therapeutic uses : Kiranthi, Kuttam, Puttru, Vippuruthi, Pilavai. 
 Reference: Agathiyar vaithiya vallathi, pg no: 20. 
 
4. Poovarasankaai ennai 
 Dosage  : 1/4 palam 
 Therapeutic uses : Korukku, Kiranthi, Karumegam. 
 Reference: Sikicha rathna deepam, pg no: 158. 
 
5. Karpoora chinthamani maathirai 
 Dosage  : 1/2 - 1 tablet. 
 Anupaanam  : Sugar, Ghee. 
 Therapeutic uses : Soolai noi, Keel vayu. 
 Reference: Anuboga vaithiya navaneetham; part - 4, pg no: 60. 
 
6. Gurumurai pathangam 
 Dosage  : 1/2 -1 arisi eadai 
 Anupaanam  : Palm jaggery, Butter. 
 Therapeutic uses : Kiranthi, Gunmam, Narambu vaatham, 
 Reference: Anuboga vaithiya navaneetham; part - 7, pg no: 19. 
 
7. Rasakarpoora kattu 
 Therapeutic uses : Sanni, Suram, Naa varatchi. 
 Reference: Aathma ratchamirutham ennum vaithiya saara sagiragam, pg no: 149. 
 
8. Sanni maathirai 
 Dosage  : Kundriyalavu. 
 Anupaanam  : Honey. 
 Therapeutic uses : Sanni. 
 Reference: Sootchuma vaithiyam – 200.  
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MERCUROUS CHLORIDE (CALOMEL) 
INTRODUCTION 
Mercurous chloride, mercury (I) chloride or calomel is a white crystalline powder 
and very slightly soluble in water. Mercurous chloride is a less dangerous poison than 
mercuric chloride because it is much less soluble; but it is highly toxic if retained in the 
body. It is also found in nature as horn quicksilver. It was used medicinally as a 
purgative, cathartic, liver stimulant, and to eliminate parasitic worms, but is rarely so used 
today because it is readily decomposed into metallic mercury and the very poisonous 
mercuric chloride found on exposure to sunlight or if heated in the presence of moisture.  
COMPOSITION Mercurous chloride (85.0% Hg, 15.0% Cl). 
TESTS  Completely volatilizes on charcoal, without melting. 
DISTINGUISHING CHARACTERISTICS 
The sectile character and the adamantine luster distinguish it from everything 
except from the silver halides. Silver minerals melt but do not volatilize completely on 
the charcoal, leaving a flattened silver residue. In a mercury association ore the 
fluorescence is significant. 
CRYSTAL DESCRIPTION - Tetragonal -- Ditetragonal Bipyramidal 
Usually found as crystals, often minute and coating other minerals. Most often 
tabular, sometimes pyramidal. Commonly in skeletal parallel growths rather than good 
individual crystals. 
GENERAL PROPERTIES 
Chemical formula: Hg2Cl2 
Chemical name: Mercurous Chloride 
Mineralogical name: CALOMEL 
Color:   White, Yellowish gray, Gray, Yellowish white, Brown 
   (Darkening on exposure to light).  
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Habit:   Earthy - Dull, clay-like texture with no visible crystalline  
   affinities.  
             Prismatic - Crystals Shaped like Slender Prisms (e.g.  
   tourmaline). 
Molar mass:  472.09 g/mol 
Solubility in water: 0.2 mg/100 ml. 
Solubility:  Insoluble in ethanol, ether  
Luminescence: Fluorescent, Short UV=dark red, Long UV=dark red.  
Luster:   Adamantine - Resinous, translucent; fluorescent red. 
Streak:   pale yellowish white  
Hardness:  1.5-2 - Talc-Gypsum 
Specific gravity: 6.5    
Density:  6.4 - 6.5, Average = 6.45 
Melting point:  525 °C (triple point) 
Boiling point:  383 °C (sublimes) 
Diaphaneity:  Translucent to sub translucent  
Fracture:  Sectile - Curved shavings or scrapings produced by a knife  
                  blade, fracture conchoidal (e.g. graphite) 
Refractive index (nD) - 1.973  
Highly reactive with metals except Sn, Pb, Ag, Au 
STRUCTURAL PROPERTIES 
 Mercury is unique among the group of 12 metals for its ability to form the M –M 
bond so readily. Hg2Cl2 is a linear molecule. The crystal structure is unit cell distorted 
octahedral coordination of mercury. The chemical bonding are  
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 The Hg–Hg bond length of 253 pm (Hg – Hg in the metal is 300 pm) and the  
Hg – Cl bond length in the linear Hg2Cl2 unit is 243 pm. 
 The overall coordination of each Hg atom is octahedral as, in addition to the two 
nearest neighbors, there are four other Cl atoms at 321 pm.  
PREPARATION  
 Mercurous chloride is prepared by sublimation from a mixture of mercury and 
mercuric chloride or by precipitation from a mercurous chloride solution on adding 
chloride ion. . It may be obtained by heating mercury in chlorine, or by reducing mercuric 
chloride (corrosive sublimate) with mercury or sulphuric acid. It is manufactured by 
heating a mixture of mercurous sulphate and common salt in iron retorts, and condensing 
the sublimed calomel in brick chambers. In the wet way it is obtained by precipitating a 
mercurous salt with hydrochloric acid. Long continued boiling with water gives mercury 
and mercuric chloride; dilute hydrochloric acid or solutions of alkaline chlorides convert 
it into mercuric chloride on long boiling. 
CHEMICAL REACTIONS 
Mercurous chloride forms by the reaction of elemental mercury and mercuric 
chloride 
                                        Hg + HgCl2 → Hg2Cl2 
It can be prepared via metathesis reaction involving aqueous mercury (I) nitrate using 
various chloride sources including NaCl or HCl. 
                                       2HCl + Hg2(NO3)2 → Hg2Cl2 + 2HNO3 
Ammonia causes Hg2Cl2 to disproportionate: 
                                         Hg2Cl2 + 2NH3 → Hg + Hg (NH2) Cl + NH4Cl  
REACTIVITY PROFILE 
 Mercurous Chloride is incompatible with acetylene, ammonia, chlorine dioxide, 
azides, calcium (amalgam formation), sodium carbide, lithium rubidium and copper. 
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HEALTH HAZARD 
Acute poisoning can result from inhaling dust concentrations of 1.2-8.5 mg/m 3 in 
air; symptoms include pain and tightness in chest, coughing, and difficulty in breathing. 
Compound is an irritant, cathartic, or purgative; rarely, “calomel sickness,” a benign 
reaction with fever and rash, appears after about 1 week; seldom causes systemic 
poisoning but may be fatal if retained to 30-40 mg/kg. Contact with eyes causes mild 
irritation. 
EMERGENCY   
Eye contact: Immediately flush the eye with water. If irritation persists, go for  
                       medical help.  
Skin contact:  Wash off with soap and water.  
  Do not discard into a sink or into normal solid waste containers.  
   Wear Protective equipment, safety glasses, and gloves. 
TOXICOLOGICAL ASPECT  
May be fatal if swallowed or inhaled. Chronic exposure may lead to systemic 
effects and build-up of mercury in the brain, liver and kidneys. May cause memory loss, 
tremors and other serious effects.  
LD50 - 210 mg/ kg.b.wt on oral administration to rat.( Thomas W. Clarkson)  
 
REPRODUCTIVE AND 
DEVELOPMENTAL TOXICITY 
 
CALOMEL 
 
MERCURY 
 
CA Prop 65 Developmental Toxin 
 
 
Yes 
 
 
Yes 
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Symptoms of Calomel Exposure from the International Chemical Safety Cards 
(ICSC) (Thomas W. Clarkson) 
 
ROUTE OF 
EXPOSURE 
 
SYMPTOMS 
 
FIRST AID 
Inhalation 
 
Cough. Sore throat. 
 
Fresh air rest. Refer for 
medical attention. 
Skin 
 
 
 
 
May be absorbed. Redness 
may develop. 
 
 
 
Remove contaminated 
clothes. Rinse skin with 
plenty of water or shower. 
Refer for medical 
attention. 
Eyes 
 
 
 
 
Redness may be developed. 
 
 
 
First rinses with plenty of 
water for several minutes 
(remove contact lenses if 
easily possible) then take 
to a doctor. 
Ingestion 
 
 
Abdominal pain. Diarrhoea. 
Vomiting. Metallic taste. 
 
 
Rinse mouth. Induce 
vomiting (ONLY IN 
CONSCIOUS PERSONS). 
Refer for medical 
attention. 
 
AQUATIC ECOTOXICITY 
All Toxic Effects for Organism Group 
 
ORGANISM GROUP 
 
EFFECTS NOTED 
Aquatic Plants Cell(s) 
Echinoderms Development 
Fish Mortality 
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Insects Intoxication 
Mollusks Accumulation, Biochemistry 
Nematodes and Flatworms Development, Mortality 
Zooplankton Mortality 
 
 
 
 
ORGANISM GROUP 
 
AVERAGE ACUTE TOXICITY 
 
Fish 
 
Moderately Toxic  
 
Nematodes and Flatworms 
 
Slightly Toxic  
 
Zooplankton 
 
Very Highly Toxic  
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3.8 KAANTHAM 
(Magnetic oxide of iron) 
Introduction: 
There are different varieties of magnet, such as, Kal kaantham, Oosi kaantham, 
Pachai kaantham, Arakku kaantham, Mayir kaatham, Urulai kaantham, Palagai kaantham 
and thagattu kaantham. In general, the magnetic oxide of iron has got the properties as 
iron. However, it is considered that the magnetic oxide of iron is superior to iron in many 
aspects. 
¸¡ó¾ò¾¡ü §º¡¨ÀÌýÁí ¸¡Á¢Ä§Á ¸õÀ¡ñÎ 
§º÷ó¾¾¢¡¢ §¾¡¼¦Åð¨¼ º£¾í¸¡ø - ´öó¾Àº¢ 
§ÀÕ¾Ãí ¸ñ§½¡ö À¢ÃÁ¢Â¿£ Ã¡¨ÁÔõ§À¡õ  
µ¡¢É¢¨Ã Â¡ÔÙõ ¯ý. 
     (Gunapaadam, Thathu-Jeeva vaguppu) 
    This is very effective in the treatment of swelling, ulcer(gunmam), jaundice 
(kaamaalai), venereal diseases of three humours, leucorrhoea(vellai), kapha vadha 
diseases, dyspepsia(mantham), anasarca (mahodaram), eye diseases, 
gonorrhoea(brahmiyam), and spleenomegaly. It also increases longevity. 
Purification and detoxification: 
1. Magnetic oxide of iron   35 gm 
Root bark juice of Tanner’s cassia  210gm 
(Cassia auriculata)- Ponnavarai 
Magnet is soaked in root juice of Tanner’s cassia and is kept in sunlight from 
morning to evening for ten days. Then it is dried for two days without adding the juice. 
This process is repeated twice and washed to obtain purified and detoxified magnet. The 
medicine manufactured from this magnetic oxide destroys diseases of vatha and protects 
life. 
2. Magnetic oxide of iron   35gm 
Juice of Kondrai (Cassia fistula) 280gm 
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Basil (Ocimum sanctum)   280gm 
Indian pennywort (Centella asiatica)  280gm 
Magnet is soaked in Indian laburnum (Cassia fistula) and kept in sunlight for nine 
days. (Daily fresh juice should be used). Then it is dried without adding the juice. This 
process is repeated with the leaves juice of basil (Ocimum sanctum) and Indian 
pennywort (Centella asiatica). After twenty seven days, the purified form of magnetic 
oxide of iron is obtained. 
3. The magnetic oxide iron is powdered and wrapped in a cloth. It is boiled with 
Kaadi (vinegar steam) and with the steam of horse gram decoction then it is boiled, 
washed and dried.  
4. The magnetic oxide of iron is soaked in lemon juice, sour butter milk for three 
days in each. It is then dried in sunshine, and washed. Thus it is purified form is obtained. 
5. The magnetic oxide of iron is heated in a furnace and dipped in horse gram 
decoction for 7 to 21 times to get it in purified form. 
Antidote for metal poisoning: 
The toxic symptoms may be occur with metal containing preparations (without 
iron). For this, Aya chenduram or Aya parpam or iron mixed tablets is used as antidote. 
MAGNETIC OXIDE OF IRON 
Introduction: 
Magnetite is a mineral, one of the two common naturally occurring oxides of 
Iron (chemical formula Fe3O4) and a member of the spinel group. Magnetite is the 
most magnetic of all the naturally occurring minerals on Earth. Naturally magnetized 
pieces of magnetite, called lodestone, will attract small pieces of iron, and this was how 
ancient people first noticed the property of magnetism. 
General decription: 
Category  : Oxide minerals – Spinel group 
Formula  : Iron(II,III) oxide, Fe2+Fe3+2O4 
Colour   : Black, gray with brownish tint in reflected sun 
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Crystal habit  : Octahedral, fine granular to massive 
Crystal system : Isometric Hexoctahedral 
Tenacity  : Brittle 
Luster   : Metallic 
Streak   : Black [1] 
Specific gravity : 5.17–5.18 
Solubility  : Dissolves slowly in hydrochloric acid 
Properties: 
· Lodestones were used as an early form of magnetic compass. Magnetite typically 
carries the dominant magnetic signature in rocks, and so it has been a critical tool 
in paleomagnetism, a science important in discovering and understanding plate 
tectonics and as historic data for magnetohydrodynamics and other scientific 
fields.  
· Magnetiteand other heavy minerals (dark) in a quartz beach sand (Chennai, India). 
· Magnetite is sometimes found in large quantities in beach sand. Such black 
sands (mineral sands or iron sands) are found in various places, such 
as California and the west coast of the North Island of New Zealand. The 
magnetite is carried to the beach via rivers from erosion and is concentrated via 
wave action and currents.( Templeton.) 
· Huge deposits have been found in banded iron formations. These sedimentary 
rocks have been used to infer changes in the oxygen content of the atmosphere of 
the Earth. 
Transformation of ferrous hydroxide into magnetite: 
Under anaerobic conditions, the ferrous hydroxide (Fe(OH)2 ) can be oxidized by 
the protons of water to form magnetite and molecularhydrogen. This process is described 
by the Schikorr reaction: 
3 Fe(OH)2 → Fe3O4 + H2 + 2 H2O 
Ferrous hydroxide → magnetite + hydrogen + water 
The well-crystallized magnetite (Fe3O4) is thermodynamically more stable than 
the ferrous hydroxide (Fe(OH)2 ). 
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Biological occurrences: 
§ Biomagnetism is usually related to the presence of crystals of magnetite, which 
occurs widely in organisms. (H. A. Lowenstam)  
§ These organisms range from bacteria (e.g., Magnetospirillum magnetotacticum) to 
several animals, where these crystals are found in the brain. (Massart, R) 
§ These crystals are thought to be involved in magnetoreception, the ability to sense 
the polarity or the inclination of the Earth'smagnetic field, and to be aid 
in navigation. 
Catalysis: 
Magnetite is the catalyst for the industrial synthesis of ammonia.  
As a sorbent 
· Magnetite powder efficiently removes arsenic(III) and arsenic(V) from water, the 
efficiency of which increases ~200 times when the magnetite particle size 
decreases from 300 to 12 nm. 
· Arsenic-contaminated drinking water is a major problem around the world, which 
can be solved using magnetite as a sorbent. 
Other: 
· Because of its stability at high temperatures, it is used for coating industrial 
watertube steam boilers.  
· The magnetite layer is formed after a chemical treatment (e.g. by 
using hydrazine). 
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3.9 SAATHIKAI  
(Common Nutmeg, Myristica fragrens Houtt) 
Introduction: 
 It is a fragrant fruit cultivated in the East India, Ceylon, Malabar, Nilgris and 
other places. The outer portion which forms the kernal of the fruit is yellowish, the seed is 
within this. The aromatic veins coated over the seed are known as mace (Saathipathiri). 
 Saathikkai is also called as Kulakkai. 
Parts used:  
 Seeds. 
Action: 
  Stimulant  Carminative 
  Narkotic   Aromatic 
  Aphrodisiac  Tonic 
General properties: 
 ¾¡Ð ¿ð¼õ §À¾¢ ºÕÅ¡º¢ Âïº¢Ã §¿¡ö 
µÐÍÅ¡ ºí¸¡ºõ ¯ð¸¢Ã½¢ - §Å§¾¡ 
ÊÄì¸¡ö ÅÕõÀ¢½¢§À¡õ ²üÈÁÂø À¢ò¾í 
ÌÄì¸¡ ÂÕóÐÅ÷ìÌì ÜÚ. 
(Gunapaadam – Mooligai Vaguppu) 
In Siddha medicines, it is useful in cases of spermatorrhoea or loss of semen, 
diarrhoea due to the derangement of vatham. 
The expressed oil is useful application for ulcers, sores, wounds, etc, and also 
serves in cases of rheumatism, paralysis, sprains, etc.The oil is applied with advantage for 
tooth ache. It is helpful in atonic diarrhoea, dysentery and dyspepsia. 
The powder form of saathikkai is prescribed for quenching the thirst of cholera 
patients. Externally, it is applied around the eyes for getting bright eyes.                             
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Scientific classification: 
Kingdom : Plantae 
Order  : Magnoliales 
Family  : Myristicaceae 
Genus  : Myristica 
Species : fragrens                                                                                                                 
The nutmeg tree is any of several species of trees in genus Myristica. The most 
important commercial species is Myristica fragrans, an evergreen tree is important for 
two spices derived from the fruit: nutmeg and mace( Encyclo)  
Essential oils: 
The essential oil obtained by steam distillation of ground nutmeg is used widely in 
the perfumery and pharmaceutical industries. This volatile fraction typically contains 60-
80% d-camphene by weight, as well as quantities of d-pinene, limonene, d-borneol, l-
terpineol, geraniol, safrol, and myristicin (Merck Index).  
The oil is colourless or light yellow, and smells and tastes of nutmeg. It contains 
numerous components of interest to the oleochemical industry, and is used as natural food 
flavouring in baked goods, syrups, beverages, and sweets. The essential oil is also used in 
the cosmetic and pharmaceutical industries, for instance, in toothpaste, and as a major 
ingredient in some cough syrups. In traditional medicine, nutmeg and nutmeg oil were 
used for disorders related to the nervous and digestive systems. 
After extraction of the essential oil, the remaining seed, containing much less 
flavour, is called "spent". Spent is often mixed in industrial mills with pure nutmeg to 
facilitate the milling process, as nutmeg is not easy to mill due to the high percentage of 
oil in the pure seed.  
Nutmeg butter: 
Nutmeg butter is obtained from the nut by expression. It is semi-solid, reddish 
brown in colour, and tastes and smells of nutmeg. Approximately 75% (by weight) of 
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nutmeg butter is trimyristin, which can be turned into myristic acid, a 14-carbon fatty 
acid, which can be used as a replacement for cocoa butter, can be mixed with other fats 
like cottonseed oil or palm oil, and has applications as an industrial lubricant. 
Common uses: 
· Nutmeg and mace have similar sensory qualities, with nutmeg having a slightly 
sweeter and mace a more delicate flavour.  
· In Indian cuisine, nutmeg is used in many sweet as well as savoury dishes 
(predominantly in Mughlai cuisine). It is also added in small quantities as a 
medicine for infants. It may also be used in small quantities in garam masala. 
Ground nutmeg is also smoked in India. 
· In originally European cuisine, nutmeg and mace are used especially in potato 
dishes and in processed meat products; they are also used in soups, sauces, and 
baked goods. In Dutch cuisine, nutmeg is added to vegetables such as Brussels 
sprouts, cauliflower, and string beans.  
· Japanese varieties of curry powder include nutmeg as an ingredient. 
Medicinal: 
 Used as an anti-diarrhoea agent for patients with medullary carcinoma of the 
thyroid.  The effectivenes of the treatment may be due to the inhibition of prostaglandin 
synthesis in the mucosa and submucosa of   the colon.  The dosage given was 9 
tablespoons orally per day but it may vary between patients to avoid toxic symptoms. 
High risk circumstances: Abuse    
 Nutmeg has been known for its hallucinogenic properties for a long time.  
Adults may abuse the hallucinogenic properties of nutmeg.  Children may be at high risk 
at home, since nutmeg may be widely available as a cooking additive.  In the course of its 
use in traditional medicine, overdose may occur. 
Medical research: 
Nutmeg has been used in medicine since at least the seventh century. In the 19th 
century it was used as an abortifacient, which led to numerous recorded cases of nutmeg 
66 
 
poisoning. Although used as a folk treatment for other ailments, unprocessed nutmeg has 
no proven medicinal value today (Shafer, Jack).  
One study has shown that the compound macelignan isolated from Myristica 
fragrans may exert antimicrobial activity against Streptococcus mutans(Devi, P. B.).  
A methanolic extract from the same plant inhibited Jurkat cell activity in human 
leukemia, but these are not currently used treatments. 
TOXICOLOGICAL ASPECT 
Poisonous parts: 
             The seeds (nutmeg) and, to a lesser extent, the aril (mace). 
Main toxins: 
 Myristicin  
 elemicin, but intoxication is not thought to be due to these alone. 
Main risks and target organs: 
· transient psychosis 
· possibility of fatty liver and hepatic necrosis 
· transient renal toxicity 
· possible carcinogen and teratogen 
· possibility of death occurring 
CLINICAL EFFECTS 
Acute poisoning: 
 In the toxic state, the patient first feels excited and may have psychedelic 
hallucinations.  This is followed by a period of drowsiness, delirium and, possibly, 
unconsciousness.  Thirst has been reported.  Mental concentration may either be impaired 
or enhanced; delirium with agitation, disorientation and incoherence may develop.  Prison 
inmates taking nutmeg "trips" have compared it to alcohol, heroin and "high", relaxed and 
drowsy.  Some reported a sleepy feeling, others, restlessness and tense.  Most patients 
with accidental nutmeg intoxication experience an impending sense of doom after the 
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initial excitation.  The effects of nutmeg are most often compared to those of marihuana.  
Although the hallucinogenic effects of nutmeg are satisfactory, the side effects often 
discourage its use as such an agent.   
Chronic poisoning 
 Chronic poisoning by oral administration has caused temporary psychosis in 
prison inmates (up to six months). 
Course, prognosis, cause of death: 
 Not all the symptoms listed below appear in every case poisoning.  
Contradicting symptoms may occur at different times during the course of intoxication. 
The subject initially feels excited, then drowsy before a delirious state sets in.  This is 
followed by a deep sleep. During this period, cyanosis of the extremities and convulsions 
may occur.  Generally there is tachycardia and an increase in blood pressure.   
 Acidosis may set in because of diarrhoea and vomiting which is usually present 
along with various other gastrointestinal symptoms such as abdominal cramps.  The 
subject may or may not be hallucinating but usually expresses a feeling of impending 
doom.  Nutmeg intoxication usually clears by itself within 24 hours, however, it has been 
reported that psychosis may set in. Transient renal toxicity has also been reported causing 
an increase in albumin and non-protein nitrogen content in the urine, returning to normal 
within 24 hours.  
Systematic description of clinical effects 
Cardiovascular 
· Tachycardia. 
· Hypertension or hypotension may occur. 
· Chest pains or tightness in chest. 
Neurological 
Central nervous system (CNS) 
· Severe headaches. 
· Drowsiness several hours after taking nutmeg. 
68 
 
· Fitful sleep/convulsions. 
· Hallucinations (predominantly visual).  
· Sedation. 
· Euphoria. 
· Concentration may be impaired or improved. 
· Excitation resembling that caused by anticholinergic intoxication.                              
· Feeling of impending doom. 
 Sometimes unusual behaviour occurs during intoxication such as hysteria and 
wild trashing of limbs, and behaviour resembling that of a snarling dog. 
Peripheral nervous system 
· Initial stimulation after administration. 
· Strong tingling in the fingers and toes shortly after snuffing some     nutmeg. 
· Numbness in hand and feet half an hour after snuffing nutmeg. 
· Absent limb reflexes. 
Autonomic nervous system 
· Profuse sweating several hours after administration possibly reflecting 
amphetamine-type reaction. 
· Absence of salivation. 
Skeletal and smooth muscle 
 Muscular excitation several hours after administration. 
Gastrointestinal 
· Nausea. 
· Vomiting. 
· Diarrhoea. 
· Abdominal pain. 
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Hepatic 
· Hepatic necrosis in heavy poisoning. 
· Fatty degradation of liver. 
Renal 
 Transient renal toxicity producing albuminuria.   
 Non-protein nitrogen content in urine which returns to normal within 24 hours. 
Summary of clinical effects: 
 Nutmeg intoxication resembles anticholinergic intoxication, e.g. profuse 
sweating, flushed face, delirium, dry throat etc.  There is always an altered state of mind, 
e.g. hallucinations, confusion and an impending sense of doom.  Clinical symptoms may 
be contradictory depending on the length of time lapsed after ingesting the toxin.  
Symptoms also vary according to the dose taken and the variability between different 
samples of nutmegs. 
Psychoactivity and toxicity: 
In low doses, nutmeg produces no noticeable physiological or neurological 
response, but in large doses, raw nutmeg has psychoactive effects. In its freshly-ground 
(from whole nutmegs) form, nutmeg contains myristicin, a monoamine oxidase inhibitor 
and psychoactive substance. Myristicin poisoning can induce convulsions, palpitations, 
nausea, eventual dehydration, and generalized body pain (Demetriades, A. K). It is also 
reputed to be a strong deliriant (Erowid).  
In case reports, raw nutmeg produced anticholinergic-like symptoms, attributed to 
myristicin and elemicin (Weil, Andrew).  
In case reports intoxications with nutmeg had effects that varied from person to 
person, but were often reported to be an excited and confused state with headaches, 
nausea and dizziness, dry mouth, bloodshot eyes and memory disturbances. Nutmeg was 
also reported to induce hallucinogenic effects, such as visual distortions and paranoid 
ideation. In the reports nutmeg intoxication took several hours before maximum effect 
was reached. Effects and after-effects lasted up to several days (Brenner, N).  
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Myristicin poisoning is potentially deadly to some pets and livestock, and may be 
caused by culinary quantities of nutmeg harmless to humans. For this reason, it is 
recommended not to feed eggnog to dogs.[30] 
Toxicity during pregnancy: 
Nutmeg was once considered an abortifacient, but may be safe for culinary use 
during pregnancy. However, it inhibits prostaglandin production and contains 
hallucinogens that may affect the fetus if consumed in large quantities (Herb and drug 
safety chart).  
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3.10 KUPPAIMAENI 
(Acalypa indica) 
Description: 
Acalypha indica Linn is a member of the Euphobiaceae family. It is essentially a 
weed which grows in waste areas. It is an erect, annual herbaceous plant with numerous 
ascending branches. Flowers are unisexual. Fruit capsules are small, concealed by the 
bracts. The seeds are ovoid, smooth, pale brown in colour. 
Arimanjari, Poonai vanangee, Maarjaala moghini are some other names. 
Plant Part Used: 
Whole plant 
Action: 
  Anodyne   Anthelmintic 
  Cathartic   Diuretic 
  Emetic    Expectorant 
General properties: 
¾ó¾ã ÄôÀ¢½¢¾£ò ¾ó¾¢ÎÒñ º÷ÅÅ¢¼õ 
¯óÐÌýÁõ Å¡¾õ ¯¾¢Ãã- Äó¾¢É× 
ÝÄïÍ Å¡ºõ ¦¾¡¼÷À£ ºí¸Àõ§À¡õ 
»¡Äí¦¸¡û §ÁÉ¢Â¾ É¡ø. 
         (Gunapaadam, Mooligai Vaguppu) 
 The leaves are very helpful in gum diseases, burnt ulcers and in plant toxins. It is 
also used in colic pain, itching, vatha diseases, pricking pain and kapha diseases. 
 It may be taken as decoction form or in powder form or as fresh extract. 
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Chemical Constituents: 
Kaempferol glycosides, mauritianin, clitorin, nicotiflorin and biorobin, acalyphin, 
epiacalyphin, tannins, beta-sitosterol, acalyphamide, aurantiamide, succinimide, 
flindersin, triacetonamine, n-octacosanol, quebrachitol, hydrocyanic acid. 
Traditional Use: 
Tribes of Kerala, Rajasthan and Madhya Pradesh use fruits: in asthma, cough, 
bronchitis and earache; plant and fruit: as an expectorant, laxative, pneumonia and 
rheumatism; leaf: in skin diseases like scabies.  
Acalypha indica is considered by the traditional practitioners to be bitter, acrid, 
expectorant, purgative, emetic, gastrointestinal irritant and diuretic. (P. K. Warrier) 
The leaves are known to have laxative properties and are given in the form of 
powder or decoction by Indians to treat constipation. In cases of obstinate consitipation 
the leaves are grounded into paste and made into a ball and introduced per rectum. It is 
supposed to relax the sphincter ani and produces free motion. In Madagascar, the root 
decoction is used as a laxative. A. indica is also considered as a vermifuge in this case the 
root infusion is being used by people of Seychelles and Reunion Islands. On the other 
hand the Indians make use of the leaves together with garlic to expel the vermins.  
The leaves are considered as an emetic and most practitioners make use of the leaf 
sap as part of a concoction to induce vomiting. It is considered as safe even for children.   
Kupaimaeni is considered an expectorant and the juice expressed from the leaves 
is being given to treat croup, while in smaller doses it helps in productive cough by aiding 
its expectoration. The root infusion or decoction is given for asthma.  
The leaves  of  Kupaimaeni  has been advocated for use in the treatment of various 
parasitic skin conditions. One of the most common applications is the treatment of 
scabies.  
East Africans use the leaf sap to treat eye infection while in Namibia the decoction 
is instilled into the eye for the same purpose. In India a decoction of the leaves is instilled 
into the ears to treat otalgia and otitis.  
In Comoros, the leaf decoction is used in cream form to treat joint pains and 
rheumatism, while in India the leave juice mixed with oil is used instead. Poultice of the 
plant is applied to the head for headache. (Gabriëlla Harriët Schmelzer)  
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Pre-Clinical Data 
Pharmacology 
Postcoital infertility activity: 
This effect is due to some estrogenic activity as evidenced by histological studies of the 
uterus. (Hiremath SP)  
Wound healing activity: 
Studies found that A. indica does have wound healing ability, however, it is 
inferior to Heliotropium indicum which has better activity and tensile strength.   
Neutralisation potential of Viper venom activity: 
The viper venom induced lethality by haemorrhage, necrotisation and mast cell 
degranulation in rats and cardiotoxicity and neurotoxicity in frogs. Preadministration of 
the ethanol leaf extracts to test animals was found to significantly inhibit these effects. It 
was found that the extract also inhibited venom-induced lipid peroxidation in RBC, 
decrease GSH and catalase levels in rat kidney tissue. This indicates that the ethanol leaf 
extract of Acalypha indica possesses potent snake venom neutralising 
properties. (Shirwaikar A, et al)  
Antibacterial activity: 
A study of the antibacterial activity of 4 different extracts (hexane, chloroform, 
ethyl acetate and methanol) from the leaves of A. indica was carried out against Gram 
positive (Staphylococcus aureus, Staphylococcus epidermidis, Bacillus cereus, 
Streptococcus faecalis) and Gram negative (Klebsiella pneumoniae, Escherichia coli, 
Proteus vulgaris, Pseudomonas aeruginosa) bacteria. All the extracts exhibited 
antibacterial activity against the Gram positive organisms with MIC 0.156 to 2.5 mg/mL 
while amongst the Gram negative bacteria only Pseudomonas aeruginosa was 
susceptible. (Govindarajan M)  
Toxicities: 
The raw herb is considered poisonous, emetic, and causes intestinal irritation. 
Pollens may cause allergy. (C. P. Khare, 2004)  
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MATERIALS AND METHODS. IV 
COLLECTION, IDENTIFICATION, PURIFICATION AND PREPARATION OF 
PUTTRU PATHANGAM 
COLLECTION OF DRUG:                          
 The raw drugs were collected from country drug merchant shop, Thakkalai, 
Kanyakumari. 
AUTHENTICATION: 
 The raw drugs were authenticated by Siddha Central Research Institute, 
Chennai. The plant drugs were authenticated by Department of Medicinal Botany, 
National Institute of Siddha.  
PREPARATION :  Gunapaadam Lab, National Institute of Siddha.  
METHODS OF PURIFICATIONS: 
Rasam 
 Mercury is mixed with the juice of whole plant of Thumbai (Leucas aspera) 4¾ 
palam (166.25gm) and insolated. This procedure is repeated for 10 days by adding fresh 
juice daily. Then it is insolated without adding the juice. This procedure is also repeated 
for one more day. Then the mercury and the powder present along with it are placed in a 
mud pot. The juice of Thumbai 2 padi (2800gm) is added, sealed and burried for 20 days. 
It is then taken out after washing with water. The purified mercury, so obtained is 
preferable for preparation of Parpam, Chenduram, Kuru,and Kuligai. 
                                                           - Gunapadam thathu Jeeva Vaguppu, Pg.no: 244  
Gandhagam 
 Gandhagam is heated with Ponankanni (Alternanthera sessilis) juice for 3 hours 
by using mild flame. Then the Gandhagam is washed with water and taken. 
  - Agathiyar attavanai vaagadam, Pg. no: 23 
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Lingam 
 Lime juice, cow’s milk and Indian Acalypha juice are mixed in equal proportion 
and allowed to fuse Cinnabar so as to get it in a consolidated potency state. 
                                                            - Gunapadam Thathu Jeeva Vagupu, Pg.no: 272  
Thalagam 
 Thalagam is bundled and boiled with lime stone water by Thulayanthiram 
method with dipping. 
                                                                              -  Saraku suthi sei muraigal, pg.no:67 
Manosilai 
 Manosilai is taken and grinded with lemon juice for 3 hours in a kalvam.  
                                                                             - Sikicha rathina deepam, Pg.no:37   
Vellai Paadanam 
 Vellai Paadana powdered and loosely bundled with a thick cloth. Milagu (Piper 
nigrum) is triturated with and dissolved in the one litre juice of Sirukeerai (Amaranthus 
tricolor) in a mud pot.By the method of thulayanthiram, bundled paadanam is dipped into 
the mixture without touching the vessel. It is boiled using low intensity fire till drying of 
the mixture and washed with water  and taken out .Repeat the process for 3 times.  
                                                            - Gunapadam Thathu Jeeva Vagupu, Pg.no: 359              
Pooram             
 Vetrilai(Piper betel) and Milagu(Piper nigrum) is taken separately equal to the 
weight of Pooram. Grinded paste of Vetrilai and Milagu is mixed with water in a mud 
pot. By the method of thulaiyandram prepared pooram is tied immersed into the mixture 
and taken after boiled well. 
                                                                                 -  Sikicha rathina deepam, Pg.no:37 
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Gaantham 
 Gaantham is taken and ground with lemon juice for 3 hours and soaked with 
lime juice for 45 minutes to get it in a purified form. 
                                                                    -Saraku suthi sei muraigal, pg.no:28 
METHOD OF PREPARATION: 
Ingredients:  
 Purified Rasam (Mercury)    -1 palam(35 gm), 
 Purified Gandhagam (Sulphur)   -1 palam (35 gm), 
 Purified Lingam (Cinnabar)    -1 palam (35 gm), 
 Purified Thalagam (Arsenic trisulphide)  -1 palam (35 gm),  
 Purified Manosilai (Arsenic disulphide)  -1 palam (35 gm), 
 Purified Vellai Paadanam (White arsenic)  -1 palam (35 gm), 
 Purified Pooram (Calomel)    -1 palam (35 gm), 
 Purified Gaantham (Magnetic oxide of iron) -1 palam (35 gm), 
 Purified Saathikkai (Myristica fragrens  -1 palam (35 gm) 
 Juice of Kuppaimaeni (Acalypha indica)  -Required quantity.  
 Purified Soatruppu (Common salt)   -2 padi 
 Purified Rasam and Gandhagam are ground well till it becomes dark colour. 
Except salt, all other ingredients are powdered separately and ground with Kuppaimaeni 
juice for one hour. The above paste is applied on a soft cloth and dried. The total amount 
of salt is divided into two; one half is put at the bottom of a mud pot and the processed 
cloth is placed above the salt. Then the remaining amount of salt is put over the processed 
cloth. The above set is covered with a suitable mud plate. The margins are covered with 7 
layers of clay cloth, dried and is burnt for 3 saamam (9 hr). Being cooled, the lid is 
opened and the sublimated medicine over the wall of the vessel is kept in a container. 
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Therapeutic dose:   1/4 – 1/2 kundri (32.5 – 65mg), twice a day or once in morning  
           according to the temperament of body. 
Adjuvant               :   1/2 Aalaku (168 ml) cow’s milk                           
Therapeutic uses :  Puttru(Cancer in cheek- breast mouth sexual organs, legs), Vellai     
                                   Kuttam (vitiligo), Kandamaalai (cervical adenitis).               
Precautions       :   Avoid tamarind. Fried salt should be used..                                                                     
                                                 -  Anuboga vaithiya navaneetham, part - 10, page no 53 
                                                                                                         year of edition -1995                           
 
 




78 
4.2. QUALITATIVE ANALYSIS 
PHYSICO-CHEMICAL PROPERTIES  
EXPERIMENTAL PROCEDURES:  Done at Biochemistry Lab, NIS and  
            SAIF, IIT Chennai-36.    
Colour:               
About 50 gm of Puttru Pathangam was taken in a clean glass beaker and tested 
for its colour by viewing against a white opaque back ground under direct sunlight. 
Odour:          
About 50 gm of the Puttru Pathangam was placed in 100 ml of beaker and tested 
for its odour by wafting the air above the beaker.  
pH         
The ph of the Puttru Pathangam was estimated as per the method prescribed in 
the Indian standard (IS) - 6940(1982). One gram of Puttru Pathangam was taken into a 
100ml graduated cylinder containing about 50 ml of water and filled up to the mark with 
water. The cylinder was stopped and shaken vigorously for two minutes and the 
suspension was allowed to settle for an hour at 25 to 27˚C. About 25 ml of the clear 
aqueous solution was transferred into a 50 ml beaker and tested for pH using DIGISUN 
digital PH meter (DIGISUN electronics, Hyderabad, India). 
Determination of Ash value:  
Two gms of the Puttru Pathangam was weighed accurately in tarred platinum or 
silica dish and incinerated at a temperature not exceeding 450˚C until free from carbon, 
then cooled and weighed. Calculate the percentage of ash with reference of the air dried 
drug. 
Water Soluble Ash: 
  To the Gooch crucible containing the total ash, 25 ml of water was added and 
boiled for 5 minutes. The insoluble matter was collected in a sintered glass crucible or on 
ash less filter paper. Washed with hot water and ignited in a crucible for 15 minutes at a 
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temperature not exceeding 450˚C. Subtract the weight of the insoluble matter from the 
weight of the ash. The difference of the weight represents the water soluble ash. Calculate 
the percentage of water soluble ash with reference to the air dried drug. 
Acid Soluble Ash: 
Ash was boiled for 5 minutes with 25 ml of 1:1 diluted Hcl. The insoluble matter 
was collected in a Gooch crucible and placed on an ash less filter paper, washed with 
water and then ignited. Finally cooled in a  desiccator and weighed. The percentage of 
insoluble ash was calculated with reference to the air dried drug. 
Loss on drying: 
Five grams of the Puttru Pathangam was heated in a hot oven at 105˚c to a 
constant weight. The percentage loss of weight was calculated as per procedure. 
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PHYSICO CHEMICAL PROPERTIES 
 
EXPERIMENT 
 
OBSERVATION 
 
 
INFERENCE 
 
Appearance of the sample                       
    
  
 
Solubility: 
a. A little of the sample is shaken well 
with distilled water. 
b. A little of the sample is shaken well 
with con. Hcl and Con. H2SO4. 
 
Sparingly soluble 
 
 
 
 
Insoluble 
 
Presence of Silicate   
 
 
 
 
Absence of Silicate   
Action of Heat: 
A small amount of the sample is taken 
in a dry test tube and heated  gently first 
and then strong. 
 
white fumes evolved 
 
No white fumes 
evolved. 
 
 
Presence of 
Carbonate 
Absence of 
Carbonate 
 
 
Flame Test: 
A small amount of the sample is made 
into a paste with Con.Hcl in a watch 
glass and introduced into non-luminous 
part of the Bunsen flame. 
 
Appearance of bluish 
green flame 
 
No appearance of 
bluish green flame 
 
 
 
Presence of Copper 
 
                   
Absence of Copper 
Ash Test: 
A filter paper is soaked into a mixture of 
sample and cobalt nitrate solution and 
introduced into the Bunsen flame and 
ignited. 
 
Appearance of yellow 
colour flame 
 
No appearance of 
yellow colour flame 
 
Presence of Sodium 
 
Absence  of 
Sodium 
 
Preparation of extract: 
              5g of sample was taken in a 250 ml of clean beaker and 50 ml of distilled water 
was added to it. Then it was boiled well for about 10 min. Then it is allowed to cool and 
filtered in a 100 ml volumetric flask and made up to 100 ml with distilled water. This 
preparation is used for the qualitative analysis of acidic and basic radicals. 
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TEST FOR BASIC RADICALS 
 
PROCEDURE 
 
OBSERVATION 
 
INFERENCE 
Test for Potassium:                       
A pinch of sample is treated with 
2ml of sodium nitrate solution and 
then treated with 2ml of cobalt                                                                        
nitrate in 30% of glacial acetic acid 
                               
Formation of Yellow colour 
precipitate                           
No Formation of Yellow
colour precipitate 
Presence of 
Potassium 
Absence of  
Potassium 
Test for Calcium:                          
2 ml of extract is taken in a clean 
test tube. To this add 2 ml of 4% 
ammonium oxalate solution.                         
Formation of White colour 
precipitate 
No formation of White 
colour precipitate 
Presence of Calcium 
 
Absence of Calcium 
Test For Magnesium: 
To 2ml of extract, sodium 
hydroxide solution is added in 
drops to excess 
Formation of White colour 
precipitate 
No formation of White 
colour precipitate 
Presence  of  
Magnesium 
Absence of  
Magnesium 
Test For Ammonium: 
To 2ml of extract few ml of 
Nessler's reagent and excess of 
sodium hydroxide solution are 
added. 
Appearance of Brown 
colour 
No appearance of Brown 
colour 
Presence of  
Ammonium 
Absence of   
Ammonium 
Test For Sodium: 
2 pinches of the substance is made 
into paste by using Hcl and 
introduced into the blue flame of 
Bunsen burner. 
Appearance of intense 
Yellow colour 
No appearance of intense 
Yellow colour 
Presence of  Sodium 
 
Absence of Sodium 
Test for Iron (Ferrous):            
The extract is treated with Conc. 
HNO3 and ammonium thiocynate. 
Appearance of Blood red 
colour.                          
No appearance of Blood red 
colour 
Presence of Ferrous 
iron                               
Absence of Ferrous 
iron 
Test For Zinc: 
To 2m1 of the extract sodium 
Formation of White colour 
precipitate 
Presence  of  Zinc 
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hydroxide solution is added in 
drops to excess. 
No formation of White 
colour precipitate 
Absence of  Zinc 
Test For Aluminium: 
To the 2m1of the extract sodium 
hydroxide is added in drops to 
excess. 
Characteristic changes 
No Characteristic changes 
Presence of 
Aluminium 
Absence of  
Aluminium 
Test For Lead: 
2 ml of extract is added with 2ml of 
potassium iodide solution. 
Formation of yellow colour 
precipitate 
No formation of yellow 
colour precipitate 
Presence of  Lead 
 
Absence  of  Lead 
Test for Copper: 
a. One pinch of substance is made 
into paste with con. Hcl in a watch 
glass and introduced into the non-
luminous part of the flame. 
b. 2 ml of extract is added with 
excess of ammonia solution. 
Formation of Blue colour 
Precipitate. 
No formation of Blue colour 
Precipitate. 
Presence of Copper 
 
Absence of Copper 
 
Test For Mercury: 
2m1 of the extract is treated with 
2ml of sodium hydroxide solution. 
Formation of Yellow 
precipitate 
No formation of Yellow 
precipitate 
Presence of Mercury 
Absence of Mercury 
Test for Arsenic: 
2m1 of the extract is treated With 
2ml of sodium hydroxide solution. 
Formation of Brownish red 
precipitate 
No formation of Brownish 
red precipitate 
Presence of Arsenic 
 
Absence of Arsenic 
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TEST FOR ACID RADICALS 
 
PROCEDURE 
 
OBSERVATION 
 
INFERENCE 
Test for Sulphate: 
2 ml of the extract is added to 5 % 
barium chloride solution. 
Formation of white 
precipitate 
No formation of white 
precipitate 
Presence of 
Sulphate 
Absence of 
Sulphate 
Test for Chloride : 
The extract is treated with Silver 
nitrate solution. 
Formation of White 
precipitate 
No formation of White 
precipitate 
Presence of  
Chloride 
Absence  of  
Chloride 
Test for Phosphate : 
The extract is treated with 
ammonium molybdate and 2ml of 
conc. HNO3. 
Formation of Yellow 
precipitate 
No formation of Yellow 
precipitate 
Presence of 
Phosphate 
Absence of  
Phosphate 
Test for Carbonate : 
The substance is treated with Conc. 
Hcl. 
Formation of 
effervesence 
No formation of 
effervesence 
Presence of    
carbonate 
Absence of 
carbonate 
Test for fluoride &oxalate: 
2ml of extract is added with 2ml of 
dil. acetic acid and 2ml calcium 
chloride solution and heated. 
Formation of cloudy 
appearance 
No formation of cloudy 
appearance 
Presence of 
Fluoride & Oxalate 
Absence of 
Fluoride & Oxalate 
Test For Nitrate:                                    
1gm of the substance is heated with 
copper turnings and concentrated 
H2SO4 and viewed the test tube 
vertically down 
Characteristic changes 
                                             
No characteristic changes 
  
Presence of Nitrate  
                                                      
Absence of Nitrate 
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OTHER CONSTITUENTS 
 
PROCEDURE 
 
OBSERVATION 
 
INFERENCE 
Test for Starch:  The 
extract is added with  weak 
iodine solution.  
Formation of blue colour 
No formation of bluea 
colour 
Presence of Starch 
Absence of Starch 
Test for Reducing Sugar:    
5 ml of Benedict's 
qualitative solution is taken 
in a test tube and allowed to 
boil for 2 min. Add 8 to 10 
drops of extract and again 
boil it for 2min. The colour 
changes are noted. 
Brickred colour 
 
No brickred colour 
 
 
Presence of Reducing 
Sugar  
 
Absence of Reducing 
Sugar 
 
Test for  Alkaloids: 
a. 2ml of the extract is 
treated with 2ml of 
potassium Iodide solution 
b. 2m1 of extract is treated 
with 2ml of picric acid 
c. 2m1 of the extract is 
treated with 2ml of 
phosphotungstic acid 
 
No  Red colour 
 
Appearance of Yellow 
colour 
No  white precipitate 
 
 
- 
 
Presence of Alkaloids 
 
- 
Test for amino acids:     
Dilute extract + 2ml of 
Ninhydrin’s solution. 
Appearance of violet colour                  
No appearance of violet 
colour 
Presence of  Amino 
acids                  
Absence of  Amino 
acids 
Test for Tannic acid :        
2ml  extract is treated with 
Formation of Blue black 
precipitate 
Presence of Tannic 
acid 
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Ferric chloride.  No formation of Blue black 
precipitate 
 
Absence  of Tannic 
acid 
Test for unsaturated 
Compound: 
2ml of the extract is treated 
with 2 ml of potassium 
permanganate solution is 
added. 
 
Appearance of Green colour 
 
Appearance of Red colour 
 
Appearance of Violet colour 
 
Appearance of Blue colour 
 
Presence of 
Oxyquinole, 
Epinephrine and Pyro 
catechol 
Presence of Anti 
pyrine, Aliphatic 
amino acids and 
Meconic acid 
Presence of 
Apomorphine 
Salicylate and 
Resorcinol 
Presence of Morphine, 
Phenol 
cresol and 
Hydroquinone 
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4.3 QUANTITATIVE ANALYSIS 
INDUCTIVELY COUPLED PLASMA OPTICAL EMISSION SPECTROMETRY 
(ICP-OES) 
Introduction  
The elemental composition of a sample is often an important part of the 
information needed to assess its properties. Hence there is a need for sensitive scientific 
instrumentation like ICP-OES which plays a pivotal role in the determination of these 
elements. ICP-OES is widely employed for the estimation of metals and metalloids at 
trace, minor and major concentrations.  
Principle  
In this technique, the high temperature plasma source atomizes the sample and 
excites the atoms resulting in emission of photons .The atoms of each element in the 
sample emit specific wavelength of light. The emission spectrum from the plasma is 
dispersed by an optical spectrometer, so that intensities of the individual wavelength can 
be measured. The number of photons emitted is directly proportional to the concentration 
of the element. The photon may be detected either sequentially or simultaneously. 
Quantitative analysis is achieved by measuring the intensity of these specific wavelengths 
and after performing the calibration using known standards.  
Extraction of information  
Obtaining qualitative information, i.e., what elements are present in the sample, 
involves identifying the presence of emission at the wavelengths characteristic of the 
elements of interest. Obtaining quantitative information, i.e., how much of an element is 
in the sample, can be accomplished using plots of emission intensity versus concentration 
called calibration curves. Typical calibration graph is illustrated below. 
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Typical ICP Calibration curve 
 Perkin Elmer Optima 5300DV  
 40 M Hz RF generator; 
Range: 165-782 nm; 
Experimental Procedure: Done at SAIF, IIT Madras, Chennai-36  
Sample preparation – Microwave Digestion  
Weigh 0.25g of test sample and transfer into a liner provided with the instrument.  
Slowly add 9ml of Nitric acid or Sulphuric acid such that no piece of sample sticks on the 
slides. Mix thoroughly and allow reacting for few minutes.  Place the liner in the vessel 
jacket.  Close the screw cap hand-tight in clockwise direction. Seal the vessel and place in 
the rotor fixed in microwave. Set temperature to 180°C for 5 minutes; hold at 180°C for 
least 10 minutes.  Allow the vessels to cool down to a vessel interior temperature below 
60°C and to a vessel surface temperature (IR) below 50°C before removing the rotor. The 
digested sample was made upto 100ml with millipore water.  If visible insoluble particles 
exist, solution could be filtered through whatmann filter paper. Transfer the digested 
solution into plastic containers and label them properly.  
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X-RAY FLUORESCENCE (XRF) 
X-ray fluorescence (XRF) spectrometer is an x-ray instrument used for routine, 
relatively non-destructive chemical analyses of rocks, minerals, sediments and fluids. It 
works on wavelength-dispersive spectroscopic principles that are similar to an electron 
microprobe (EPMA). However, an XRF cannot generally make analyses at the small spot 
sizes typical of EPMA work (2-5 microns), so it is typically used for bulk analyses of 
larger fractions of geological materials. The relative ease and low cost of sample 
preparation, and the stability and ease of use of x-ray spectrometers make this one of the 
most widely used methods for analysis of major and trace elements in rocks, minerals, 
and sediment. 
Fundamental Principles of X-Ray Fluorescence (XRF) 
The XRF method depends on fundamental principles that are common to several 
other instrumental methods involving interactions between electron beams and x-
rays with samples, including: X-ray spectroscopy (e.g., SEM - EDS), X-ray diffraction 
(XRD), and wavelength dispersive spectroscopy. Analysis of major and trace elements in 
geological materials by x-ray fluorescence is made possible by the behavior of atoms 
when they interact with radiation. When materials are excited with high-energy, short 
wavelength radiation (e.g., X-rays), they can become ionized. If the energy of the 
radiation is sufficient to dislodge a tightly-held inner electron, the atom becomes unstable 
and an outer electron replaces the missing inner electron. When this happens, energy is 
released due to the decreased binding energy of the inner electron orbital compared with 
an outer one. The emitted radiation is of lower energy than the primary incident X-rays 
and is termed fluorescent radiation. Because the energy of the emitted photon is 
characteristic of a transition between specific electron orbital in a particular element, the 
resulting fluorescent X-rays can be used to detect the abundances of elements that are 
present in the sample. 
Procedure 
The analysis of major and trace elements in geological materials by XRF is made 
possible by the behavior of atoms when they interact with X-radiation. An XRF 
spectrometer works because if a sample is illuminated by an intense X-ray beam, known 
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as the incident beam, some of the energy is scattered, but some is also absorbed within the 
sample in a manner that depends on its chemistry. The incident X-ray beam is typically 
produced from a Rh target, although W, Mo, Cr and others can also be used, depending 
on the application.  
 
When this primary X-ray beam illuminates the sample, it is said to be excited. The 
excited sample in turn emits X-rays along a spectrum of wavelengths characteristic of the 
types of atoms present in the sample. How does this happen? The atoms in the sample 
absorb X-ray energy by ionizing, ejecting electrons from the lower (usually K and L) 
energy levels. The ejected electrons are replaced by electrons from an outer, higher 
energy orbital. When this happens, energy is released due to the decreased binding energy 
of the inner electron orbital compared with an outer one. This energy release is in the 
form of emission of characteristic X-rays indicating the type of atom present. If a sample 
has many elements present, as is typical for most minerals and rocks, the use of 
a Wavelength Dispersive Spectrometer much like that in an EPMA allows the separation 
of a complex emitted X-ray spectrum into characteristic wavelengths for each element 
present. Various types of detectors (gas flow proportional and scintillation) are used to 
measure the intensity of the emitted beam. The flow counter is commonly utilized for 
measuring long wavelength (>0.15 nm) X-rays that are typical of K spectra from elements 
lighter than Zn. The scintillation detector is commonly used to analyze shorter 
wavelengths in the X-ray spectrum (K spectra of element from Nb to I; L spectra of Th 
and U). X-rays of intermediate wavelength (K spectra produced from Zn to Zr and L 
spectra from Ba and the rare earth elements) are generally measured by using both 
detectors in tandem. The intensity of the energy measured by these detectors is 
proportional to the abundance of the element in the sample. The exact value of this 
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proportionality for each element is derived by comparison to mineral or rock standards 
whose composition is known from prior analyses by other techniques. X-Ray 
fluorescence is particularly well-suited for investigations that involve 
· bulk chemical analyses of major elements (Si, Ti, Al, Fe, Mn, Mg, Ca, Na, K, 
P) in rock and sediment 
· bulk chemical analyses of trace elements (in abundances >1 ppm; Ba, Ce, Co, 
Cr, Cu, Ga, La, Nb, Ni, Rb, Sc, Sr, Rh, U, V, Y, Zr, Zn) in rock and sediment - 
detection limits for trace elements are typically on the order of a few parts per 
million 
X-ray fluorescence is limited to analysis of 
· relatively large samples, typically > 1 gram 
· materials that can be prepared in powder form and effectively 
homogenized 
· materials for which compositionally similar, well-characterized standards 
are available 
· materials containing high abundances of elements for which absorption 
and fluorescence effects are reasonably well understood. 
In most cases for rocks, ores, sediments and minerals, the sample is ground to a fine 
powder. At this point it may be analyzed directly, especially in the case of trace element 
analyses. However, the very wide range in abundances of different elements, especially 
iron, and the wide range of sizes of grains in a powdered sample, makes the 
proportionality comparison to the standards particularly troublesome. For this reason, it is 
common practice to mix the powdered sample with a chemical flux and use a furnace or 
gas burner to melt the powdered sample. Melting creates a homogenous glass that can be 
analyzed and the abundances of the (now somewhat diluted) elements calculated. 
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Strengths 
X-Ray fluorescence is particularly well-suited for investigations that involve: 
· bulk chemical analyses of major elements (Si, Ti, Al, Fe, Mn, Mg, Ca, 
Na, K, P) in rock and sediment 
· bulk chemical analyses of trace elements (>1 ppm; Ba, Ce, Co, Cr, Cu, 
Ga, La, Nb, Ni, Rb, Sc, Sr, Rh, U, V, Y, Zr, Zn) in rock and sediment. 
Experimental Procedure: Done at Sastra University,Tanjore.  
 
FOURIER TRANSFORM - INFRA RED SPECTROSCOPY 
Analyser:  PERKIN ELMER – SPECTRUM ONE  
Introduction  
Vibrational spectroscopy is an extremely useful tool in the elucidations of 
molecular structure. The spectral bands can be assigned to different vibrational modes of 
the molecule. The various functional groups present in the molecule can be assigned by a 
comparison of the spectra with characteristic functional group frequencies. As the 
positions of the bands are directly related to the strength of the chemical bond, a large 
number of investigations including intermolecular interactions, phase transitions and 
chemical kinetics can be carried out using this branch of spectroscopy.  
In IR spectroscopy, the resonance absorption is made possible by the change in 
dipole moment accompanying the vibrational transition. The Infrared spectrum originates 
from the vibrational motion of the molecule. The vibrational frequencies are a kind of 
fingerprint of the compounds. This property is used for characterization of organic, 
inorganic and biological compounds. The band intensities are proportional to the 
concentration of the compound and hence qualitative estimations are possible.  
The IR spectroscopy is carried out by using Fourier transform technique.  
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Principle  
Infra red spectroscopy involves study of the interaction of electromagnetic 
radiation with matter. Due to this interaction, electromagnetic radiation characteristic of 
the interacting system may be absorbed (or emitted). The experimental data consist of the 
nature (frequency of wave length) and the amount (intensity) of the characteristic 
radiation absorbed or emitted. These data are correlated with the molecular and electronic 
structure of the substance and with intra- and inter molecular interactions.  
FT-IR spectroscopy is used primarily for qualitative and quantitative analysis of 
organic compounds, and also for determining the chemical structure of inorganic 
materials. The region between 500-4000 wave numbers is referred to as the finger print 
region. Absorption bands in this region are generally due to intra molecular phenomena 
and are highly specific for each material. The specificity if these bands allow 
computerized data searches to be performed against reference libraries to identify a 
material. 
Table of Characteristic IR Absorptions 
 
frequency, cm–1 bond functional group 
3640–3610 (s,sh) O–H stretch, free hydroxyl alcohols, phenols 
3500–3200 (s,b) O–H stretch, H–bonded alcohols, phenols 
3400–3250 (m) N–H stretch 1°, 2° amines, amides 
3300–2500 (m) O–H stretch carboxylic acids 
3330–3270 (n, s) –C≡C–H: C–H stretch alkynes (terminal) 
3100–3000 (s) C–H stretch aromatics 
3100–3000 (m) =C–H stretch alkenes 
3000–2850 (m) C–H stretch alkanes 
2830–2695 (m) H–C=O: C–H stretch aldehydes 
2260–2210 (v) C≡N stretch nitriles 
2260–2100 (w) –C≡C– stretch alkynes 
1760–1665 (s) C=O stretch carbonyls (general) 
1760–1690 (s) C=O stretch carboxylic acids 
1750–1735 (s) C=O stretch esters, saturated aliphatic 
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1740–1720 (s) C=O stretch aldehydes, saturated aliphatic 
1730–1715 (s) C=O stretch α,β–unsaturated esters 
1715 (s) C=O stretch ketones, saturated aliphatic 
1710–1665 (s) C=O stretch α,β–unsaturated aldehydes, 
ketones 
1680–1640 (m) –C=C– stretch alkenes 
1650–1580 (m) N–H bend 1° amines 
1600–1585 (m) C–C stretch (in–ring) aromatics 
1550–1475 (s) N–O asymmetric stretch nitro compounds 
1500–1400 (m) C–C stretch (in–ring) aromatics 
1470–1450 (m) C–H bend alkanes 
1370–1350 (m) C–H rock alkanes 
1360–1290 (m) N–O symmetric stretch nitro compounds 
1335–1250 (s) C–N stretch aromatic amines 
1320–1000 (s) C–O stretch alcohols, carboxylic acids, esters, 
ethers 
1300–1150 (m) C–H wag (–CH2X) alkyl halides 
1250–1020 (m) C–N stretch aliphatic amines 
1000–650 (s) =C–H bend alkenes 
950–910 (m) O–H bend carboxylic acids 
910–665 (s, b) N–H wag 1°, 2° amines 
900–675 (s) C–H “oop” aromatics 
850–550 (m) C–Cl stretch alkyl halides 
725–720 (m) C–H rock alkanes 
700–610 (b, s) –C≡C–H: C–H bend alkynes 
690–515 (m) C–Br stretch alkyl halides 
 
 
 
m=medium, w=weak, s=strong, n=narrow, b=broad, sh=sharp 
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Sampling techniques:  
There are a variety of techniques for sample preparation depending on the 
physical form of the sample to be analyzed. Solid : KBr or Nujol mull method. Liquid : 
CsI / TlBr Cells Gas : Gas cells  
Experimental Procedure: Done at SAIF, IIT Madras, Chennai-36.  
KBr Method  
· The sample was grounded using- an agate mortar and pestle to give a very fine 
powder.  
· The finely powder sample was mixed with about 100mg dried KBr salt.  
· The mixture was then pressed under hydraulic press using a die to yield a 
transparent disc ( measure about 13mm diameter and 0.3mm in thickness), 
through which the beam of spectrometer passed.  
SCANNED ELECTRON MICROSCOPY (SEM) 
A SEM is essentially a high magnification microscope, which uses a focused 
scanned electron beam to produce images of the sample, both top-down and, with the 
necessary sample preparation, cross-sections. The primary electron beam interacts with 
the sample in a number of key ways:-  
v Primary electrons generate low energy secondary electrons, which tend to 
emphasize the topographic nature of the specimen.  
v Primary electrons can be backscattered which produces images with a high degree 
of atomic number (Z) contrast.  
v Ionized atoms can relax by electron shell-to-shell transitions, which lead to either 
X-ray emission or Auger electron ejection. The X-rays emitted are characteristic 
of the elements in the top few μm of the sample.  
The SEM is carried out by using FEI-Quanta FEG 200-High Resolution Instrument. 
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 Resolution  :  1.2 nm gold particle separation on a carbon substrate  
Magnification :  From a min of 12x to greater than 1, 00,000 X  
Application  : To evaluate grain size, particle size distributions, material   
              homogeneity and inter metallic distributions. 
Experimental Procedure: Done at SAIF, IIT Madras, Chennai-36  
Sample preparation:  
Sample preparation can be minimal or elaborate for SEM analysis, depending on 
the nature of the samples and the data required. Minimal preparation includes acquisition 
of a sample that will fit into the SEM chamber and some accommodation to prevent 
charge build-up on electrically insulating samples. Most electrically insulating samples 
are coated with a thin layer of conducting material, commonly carbon, gold, or some 
other metal or alloy. The choice of material for conductive coatings depends on the data 
to be acquired: carbon is most desirable if elemental analysis is a priority, while metal 
coatings are most effective for high resolution electron imaging applications. 
Alternatively, an electrically insulating sample can be examined without a conductive 
coating in an instrument capable of "low vacuum" operation.  
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4.4 TOXICOLOGICAL EVALUATION OF  
PUTTRU PATHANGAM 
Scope of the work: 
Preclinical drug development is a stage that begins before clinical trials during 
which important safety and pharmacology data are collected. Regulatory toxicity studies 
are conducted in animals to identify possible hazards from which an assessment of risk to 
humans is made by extrapolation. The choice of animal species is based on the 
similarities of its metabolism to human. 
The goals of the non clinical safety evaluation includes 
v Categorization of toxic effects with respect to target organs, dose 
dependence, relationship to exposure and potential reversibility. This 
information is important for the estimation of an initial safe starting dose for 
the human trial.  
v The identification of specific parameters for clinical monitoring for potential 
adverse effect. 
Systemic toxicity studies  
Acute oral dose toxicity study 
 Single dose studies (acute oral dose toxicity) in animals are essential for any 
pharmaceutical products intended for human use .the information obtained from these 
studies is useful in choosing doses for repeated dose studies, providing preliminary 
identification of target organs of toxicity and occasionally revealing delayed toxicity. 
Acute toxicity studies may also aid in the selection of starting doses for phase I human 
studies and provide information relevant to acute over dosing in humans 
Repeated dose systemic toxicity studies 
 The primary goal of repeated dose toxicity studies is to characterize the 
toxicological profile of the cell compound following repeated administration. This 
includes identification of potential target organs of toxicity and exposure /response 
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relationship and may include the potential reversibility of toxic effects. This information 
should be part of the safety assessment to support the conduct of human clinical trials and 
the approval of marketing authorization. 
PLAN OF WORK 
The following studies carried out in PPM are 
 Acute oral toxicity study – OECD 423 guideline 
 Repeated oral toxicity study – OECD 407 guideline 
The toxicity studies were evaluated after getting permission from the Institutional 
Animal Ethical Committee clearance.  (1248/ac/09/CPCSEA/04/IAEC 2011). 
Test drug : PUTTRU PATHANGAM - (PPP) 
Study Place : Animal house, NIS. 
PRECLINICAL ANIMAL TOXICITY STUDIES OF IN 
PUTTRU PATHANGAM RODENTS 
 
ACUTE ORAL TOXICITY – OECD-423  
Introduction:  
1. The acute toxic class method is a stepwise procedure with the use of 3 animals of 
a single sex per step. Depending on the mortality and/or the moribund status of the 
animals, on average 2-4 steps may be necessary to allow judgment on the acute 
toxicity of the test substance. This procedure is reproducible, uses very few 
animals and is able to rank substances in a similar manner to the other acute 
toxicity testing methods. The acute toxic class method is based on biometric 
evaluations with fixed doses, adequately separated to enable a substance to be 
ranked for classification purposes and hazard assessment.  
2. In principle, the method is not intended to allow the calculation of a precise LD50, 
but does allow for the determination of defined exposure ranges where lethality is 
expected since death of a proportion of the animals is still the major endpoint of 
this test. The method allows for the determination of an LD50 value only when at 
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least two doses result in mortality higher than 0% and lower than 100%. The use 
of a selection of pre-defined doses, regardless of test substance, with classification 
explicitly tied to number of animals observed in different states improves the 
opportunity for laboratory to laboratory reporting consistency and repeatability.  
PRINCIPLE  
It is the principle of the test that based on a stepwise procedure with the use of a 
minimum number of animals per, step sufficient information is obtained on the acute 
toxicity of the test substance to enable its classification. The substance is administered 
orally to a group of experimental animals at one of the defined doses. The substance is 
tested using a stepwise procedure, each step using three animals of a single sex. Absence 
or presence of compound-related mortality of the animals dosed at one step will 
determine the next step, i.e.; 
· no further testing is needed, 
· dosing of three additional animals, with the same dose  
· dosing of three additional animals at the next higher or the next lower dose 
level. The method will enable a judgment with respect to classifying the 
test substance to one of a series of toxicity classes.  
METHODOLOGY  
1. Selection of animal species  
The preferred rodent species is the rat, although other rodent species may be used. 
Healthy young adult animals of commonly used laboratory strains should be employed. 
Females should be nulliparous and non-pregnant. Each animal, at the commencement of 
its dosing, should be between 8 and 12 weeks old and its weight should fall in an interval 
within ±20 % of the mean weight of any previously dosed animals. The Wistar albino 
female species were selected. 
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2. Housing and feeding conditions:  
The temperature in the experimental animal room should be 22 ± 3ºC. Although 
the relative humidity should be at least 30% and preferably not exceed 70% other than 
during room cleaning the aim should be 50-60%. Lighting should be artificial, the 
sequence being 12 hour light, 12 hour dark. For feeding, conventional laboratory diets 
may be used with an unlimited supply of drinking water. Animals may be group-caged by 
dose, but the number of animals per cage must not interfere with clear observations of 
each animal.  
Administration of doses:  
PPP suspended in 10% aqueous tween 80 solution with uniform mixing and was 
administered to the groups of wistar rats in a single oral dose by gavage using a feeding 
needle. The control group received an equal volume of the vehicle. Animals were fasted 
for 12 hours prior to dosing. Following the period of fasting, the animals were weighed 
and then the test substance was administered. Three animals are used for each step. The 
dose level of 5, 50, 300 and 2000 mg/kg body weight was administered stepwise. After 
the substance has been administered, food was withheld for a further 3-4 hours. The 
principle of laboratory animal care was followed. Observations were made and recorded 
systematically and continuously observed as per the guideline after substance 
administration. The visual observations included skin changes, mobility, aggressively, 
sensitivity to sound and pain, as well as respiratory movements. They were deprived of 
food, but not water 16–18 hour prior to the administration of the test suspension. Finally, 
the number of survivors were noted after 24 hour and these animals were then maintained 
for a further 14 days and observations made daily. The toxicological effect was assessed 
on the basis of mortality. 
3. Test substance and Vehicle:  
 The PPP is freely soluble in water and the suspension was made with tween80 
solution for dose accuracy and easy administration in animals.  
4. Justification for choice of vehicle:  
The vehicle selected as per the standard guideline which is pharmacologically 
inert and easy to employ for new drug development and evaluation technique.  
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5. Test animals and Test conditions:  
Sexually mature Wistar albino rats (110-128g) were obtained from Sri 
Raghavendra Enterprises, Bangalore and King Institute Chennai. All the animals were 
kept under standard environmental condition (22 ± 3ºC). The animals had free access to 
water and standard pellet diet (Sai meera foods, Bangalore). Rats were deprived of food 
but not water (16-18 h) prior to administration of the PPP. The principles of laboratory 
animal care were followed.  
OBSERVATIONS:  
Animals are observed individually after dosing at least once during the first 30 
minutes, periodically during the first 24 hours, with special attention given during the first 
4 hours, and daily thereafter, for a total of 14 days, except where they need to be removed 
from the study and humanely killed for animal welfare reasons or are found dead. It 
should be determined by the toxic reactions, time of onset and length of recovery period, 
and may thus be extended when considered necessary. The times at which signs of 
toxicity appear and disappear are important, especially if there is a tendency for toxic 
signs to be delayed. All observations are systematically recorded with individual records 
being maintained for each animal. Observations include changes in skin and fur, eyes and 
mucous membranes, and also respiratory, circulatory, autonomic and central nervous 
systems, and somatomotor activity and behavior pattern, sleep and coma. The principles 
and criteria summarised in the Humane Endpoints Guidance Document taken into 
consideration. Animals found in a moribund condition and animals showing severe pain 
or enduring signs of severe distress was humanely killed. When animals are killed for 
humane reasons or found dead, the time of death should was recorded.   
Body weight:  
Individual weight of animals was determined before the test substance was 
administered and at least weekly thereafter. Weight changes was calculated and recorded. 
At the end of the study, surviving animals were weighed and humanely killed.  
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RESULTS  
All data were summarised in tabular form, (Table-7) showing for each test group 
the number of animals used, the number of animals displaying signs of toxicity, the 
number of animals found dead during the test or killed for humane reasons, time of death 
of individual animals, a description and the time course of toxic effects and reversibility, 
and necropsy findings.  
 
28-DAYS REPEATED DOSE ORAL TOXICITY STUDY OF PUTTRU 
PATHANGAM IN RATS 
 
Test Substance   : PPP 
Animal Source   : King Institute,Chennai  
Animals    : Male and Female wistar albino Rats  
Study place   : Animal house, NIS 
Age     : 6-8 weeks  
Body Weight on Day 0 : Males: Mean 108.86g Females: Mean 112.68g  
Acclimatization   : Seven days prior to dosing.  
Veterinary examination  : Prior to and at the end of the acclimatization period.  
Identification of animals  : By cage number, animal number and individual  
   marking on fur with picric acid.  
Diet     : Pelleted feed supplied by Sai meera foods Pvt Ltd,      
       Bangalore. 
Water    : Aqua guard portable water in polypropylene bottles ad  
  libitum. 
Housing & Environment  : The animals were housed in Polypropylene cages       
     provided with    bedding of husk.  
Housing temperature  : Between 22°C ±3ºC,  
Relative humidity   : Between 30% and 70%,  
Air changes    : 10 to 15 per hour  
Dark and light cycle   : 12: 12 hours.  
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Justification for dose selection: 
 As stated in results of acute oral toxicity studies in wistar rats indicated that LD 
cutoff value of PPP was 200 mg/ kg body weight. Mortality was observed in 2 animals of 
300mg/kg body weight. On the basis of these results, the doses selected for the study 
were X, 5X and 10X. The X value was calculated with the human therapeutic dose and 
the body surface area of the rat. The oral route was selected since oral route is considered 
to be a proposed therapeutic route. 
Preparation and administration of dose: 
 PPP was suspended on 10% aqueous tween 80 and administered to animals at the 
dose levels of X, 5X and 10X. The test substance suspensions were freshly prepared 
every two days once for 28 days. The control animals were administered vehicle only. 
Administration was by oral (gavage), once daily for 28 consecutive days. 
Methodology: 
Randomization, Numbering and Grouping of animals. 
 Six rats (3 male + 3 female) in each group randomly divided in to 4 groups for 
treating  the test drug up to 28 days. 
Group I :  Control receiving vehicle (10% aqueous tween 80 solution). 
Group II :  PPP at the dose level of X dose (1.17mg). 
Group III :  PPP at the dose level of 5X dose (5.85mg). 
Group IV :  PPP at the dose level of 10X dose (11.7mg). 
 The study will be carried out as per OECD Guideline 407 (28-Days Repeated 
Oral Dose Toxicity in Rodents). The animals will be divided in four groups each group 
consist of 6 animals (3 males and 3 females). One group will serve as control and the 
other three groups for test drug at three dose levels (low, mid and high) for 28 days. 
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Observations: 
          During the study, body weight of the animals will be evaluated weekly; water, 
food consumption and mortality events will be evaluated daily. By the end of 28 days, 
the animal will be sacrificed by excessive anesthesia. Blood will be collected in all 
overnight (12 hours) fasted rats through jugular vein and it will be processed for below 
mentioned investigations. Vital organs will be collected from the animals and subjected 
to histopathology.  
LABORATORY TEST: 
Complete haemogram 
Renal function test 
Liver function test    
 
GROSS NECROPSY: 
  It includes examination of the external surface of the body, all orifices, and 
organs like brain, lungs, heart, spleen, liver, kidneys, adrenals and sex organs of all 
animals. 
HISTOPATHOLOGY: 
Control and highest dose group animals will be initially subjected to 
histopathological investigations. If any abnormality found in the highest dose group 
than the low dose treated animals, then the mid dose treated animals will also be 
examined. Liver, kidney, lungs, spleen, heart and stomach will be collected from all 
animals and preserved in 10% buffered neutral formalin, sliced 5 or 6µm sections and it 
will be stained with hematoxylin and eosin, examined for histopathological changes. 
Statistical analysis:  
Findings such as clinical signs of intoxication, body weight changes, food 
consumption, haematology and blood chemistry were subjected to One-way ANOVA 
followed by dunnet‘t‘ test using a computer software programme -INSTAT-V3 version. 
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 RESULTS  .V 
 
 
PHYSICO CHEMICAL ANALYSIS 
 
Colour characters of Puttru Pathangam 
Table.3. 
 
 
 
 
Physico chemical properties of Puttru Pathangam 
 
 
 
 
 
 
 
S No 
 
Nature of the drug 
 
Under ordinary light 
 
Under ultra violet 
light 
 
1. 
 
Powdered material 
 
Brown 
 
Brown 
 
S No. 
 
Parameters 
 
Values obtained (%w/w) 
 
1. 
 
Total ash value 
 
8.45 
 
2. 
 
Acid insoluble ash 
 
0.75 
 
3. 
 
Water soluble ash 
 
7.14 
 
4. 
 
Moisture content 
 
9.22 
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Heavy/toxic metals in Puttru Pathangam 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Colour, nature and percent yields of extracts of Puttru Pathangam 
 
 
 
           
 
 
 
 
 
 
Lead 
 
BDL 
 
Cadmium 
 
BDL 
 
Mercury 
 
3.842mg/L 
 
Arsenic 
 
BDL 
 
S.No. 
 
Extract 
Solvents 
 
Colour 
 
Nature 
 
%Yield(w/w) 
 
 
pH 
 
1. 
 
Water 
 
Brown 
 
Solid 
 
48 
 
3.2-3.5 
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QUALITATIVE ANALYSIS 
 
CHEMICAL ANALYSIS 
     
The qualitative analysis of Puttru Pathangam shows the presence of 
 
· Iron 
· Chloride 
· Phosphate 
· Unsaturated compound 
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QUANTITATIVE ANALYSIS 
INDUCTIVELY COUPLED PLASMA OPTICAL EMISSION SPECTROMETRY 
 
Table. 4. 
 
 
S.no. 
 
Elements 
 
Wavelength 
in  nm 
 
PuttruPathangam 
(ppm) 
 
 
1. 
 
Arsenic 
 
As193.696 
 
BDL* 
 
2. 
 
Calcium 
 
Ca 317.933 
 
15.856 
 
3. 
 
Cadmium 
 
Cd 226.502 
 
BDL* 
 
4. 
 
Mercury 
 
Hg 253.652 
 
3.187 
 
5. 
 
Iron 
 
Fe 238.204 
 
1.356 
 
6. 
 
Potassium 
 
K 766.490 
 
45.426 
 
7. 
 
Sodium 
 
Na 589.592 
 
17.952 
 
8. 
 
Phosphorus 
 
P 213.617 
 
9.784 
 
9. 
 
Lead 
 
Pb 230.204 
 
BDL* 
 
 
           * BDL = below detection limit,   ppm – Parts per million   
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X-RAY FLUORESCENCE (XRF)                
Table.5 
 
 
 
 
 
 
Oxide form Elemental form 
Formula Z Concentration Formula Z Concentration 
Hg 80 42.14% Hg 80 42.14% 
As2O3 33 8.48% As 33 8.14% 
SO3 16 6.51% O 8 16.15% 
Cl 17 5.60% Cl 17 5.60% 
MgO 12 5.59% Mg 12 3.37% 
SiO2 14 0.57% S 16 2.61% 
Al2O3 13 0.44% Si 14 0.27% 
Fe2O3 26 0.20% Al 13 0.23% 
SeO2 34 0.14% Fe 26 0.14% 
TiO2 22 0.12% Se 34 0.10% 
PbO 82 0.09% Pb 82 0.08% 
MnO 25 0.09% Ti 22 0.07% 
Tl 81 0.02% Mn 25 0.07% 
NiO 28 0.01% Tl 81 0.02% 
   Ni 28 90 PPM 
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FOURIER TRANSFORM - INFRA RED SPECTROSCOPY 
 
4000.0 3600 3200 2800 2400 2000 1800 1600 1400 1200 1000 800 600 450.0
0.0
5
10
15
20
25
30
35
40
45
50
55
60
65
70
75
80
85
90
95
100.0
cm-1
%T 
PUTTRU  PATHANGAM 
3910
3784
3572
3396
3245
1959
1622
1414
1047
796
674
597
523
500
481
459
 
 
Table of Characteristic IR Absorptions 
 
Table.6 
 
 
frequency, cm–1 
 
bond 
 
functional group 
3640–3610 (s, sh) O–H stretch, free hydroxyl alcohols, phenols 
3500–3200 (s,b) O–H stretch, H–bonded alcohols, phenols 
3300–2500 (m) O–H stretch carboxylic acids 
1650–1580 (m) N–H bend 1° amines 
1250–1020 (m) C–N stretch aliphatic amines 
910–665 (s, b) N–H wag 1°, 2° amines 
900–675 (s) C–H “oop” aromatics 
850–550 (m) C–Cl stretch alkyl halides 
700–610 (b, s) –C≡C–H: C–H bend alkynes 
690–515 (m) C–Br stretch alkyl halides 
 
m=medium, w=weak, s=strong, n=narrow, b=broad, sh=sharp 
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SCANNED ELECTRON MICROSCOPY (SEM) 
 
Determination of particle size of Puttru Pathangam 
 
 
 
Fig.4. HR SEM – PUTTRU PATHANGAM 
 
1. Particle size is 0.25 to 0.5 µ (micron). 
 
2. Cumulative distribution of the particles with bulk density is seen. 
  
3. Surface is smooth in nature. 
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TOXICITY STUDY 
ACUTE ORAL TOXICITY STUDY 
 All the data´s were summarized in the form of table (5) showing the animals 
behavioural signs in control and test groups. Mortality noted in 2 animals at the dose 
level of 300mg/kg body weight 3 to 6 hours after the drug administration.  
Gross Necropsy: 
1. No abnormalities seen in external observation and necropsy examinations on the 
dose level of 5mg/kg bw.and 50mg/kgbw. 
2. No abnormalities seen in external observation and necropsy examinations on the 
dose level of 50mg/kgbw. 
3. In the dose level of 300mg/kg bw, mortality was noted in two animals in three 
to six hours. Colloid like defecations (3-4times), nasal discharge, clonus with 
hyper extension, fixed eyeballs were observed. Necropsy showed, frothy 
discharge from trachea, lung congestion, hyperemia in fundus of the stomach, 
bulged intestines were observed. Other vital organs were normal. 
REPEATED ORAL TOXICITY STUDY 
Clinical signs  
             No abnormal behavioural signs were observed during the study period. 
Mortality 
            The test drug Puttru Pathangam did not cause any mortality in X, 5X and 10X 
dose levels and were considered as safe dose levels. The X dose was calculated with 
the human dose and body surface area of rats. 
Body weight  
                     Both control and test dose groups exhibited normal body weight 
throughout the study period. Table. (6).  
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Food consumption  
 No difference in food intake of control and test group animals were observed 
during the period of study. Table. (8) 
Water intake 
 No difference in water intake of control and test group animals were observed 
during the period of study. Table. (7). 
Hematological   investigations  
           The results of hematological investigation conducted at the end of the study, 
test groups revealed no significant changes in values of different parameters, when 
compared with control group. The Lymphocyte count was slightly elevated in test 
groups, but statistically not significant when compared with control group. Table. (9).  
Biochemical investigations  
 Biochemical investigations were conducted at the end of the study and the 
results were recorded. In test groups there was no significant elevation in the levels of 
biochemical parameters, when compared with the control group. And the values 
obtained were within normal biological limits. Table. (10 - 12) 
Histopathology  
     Gross pathological examination of animals doesn’t reveal any abnormalities 
in control and test groups. The histopathological study of the organs such as heart, 
lungs, kidney, spleen, stomach and liver was normal in control, X, and 5X groups. In 
10X group, lung shows focal lymphoid aggregation. Liver shows portal tract with 
focal lymphoid infiltrate, radiating cords of hepatocytes, sinusoids were normal. 
Stomach shows acute and chronic inflammatory cells in lamina propria. Heart shows 
normal myocardial fibers with patterned coronaries. 
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HISTOPATHOLOGICAL REPORT 
 
HEART 
 
 
Plate .a. CONTROL 
 
Sections shows normal myocardial fibers with patterned coronaries. 
 
 
Plate .b. X group 
 
Section shows normal myocardial fibers with patterned coronaries. 
 
 
Plate .c. 5X group 
 
Section shows normal myocardial fibers with patterned coronaries. 
 
 
Plate .d. 10X group 
 
Section of the heart shows normal myocardial fibers with patterned coronaries 
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HEART 
 
                
        
 
 
    
 
      Plate.a.CONTROL                                                                 Plate.b.X group 
 
 
 
                          
                      Plate.c. 5X group                                                                      Plate.d.10X group        
                        Low power                                                                           High power       
                            
                                                                                  
            Plate d. 10X group – Scanner 
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KIDNEY 
 
 
 
Plate .a. CONTROL 
 
Specimen shows normal appearing glomeruli, tubules and intestitium. 
 
 
Plate .b. X group 
 
Specimen shows normal appearing glomeruli, tubules and intestitium.. 
 
 
Plate .c. 5X group 
 
Specimen shows normal appearing glomeruli, tubules and intestitium. 
 
 
Plate .d. 10X group 
 
Section from the kidney shows normal appearing glomeruli, tubules and intestitium.. 
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KIDNEY 
 
             
        
 
 
 
             Plate.a. Control                                                                             Plate.b. X group  
                                                                                   
                                                                                                           
        
          Plate.c. 5X group                  Plate.d. 10X group 
 
       
 
               Plate.e.10X group - high power. 
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LIVER 
 
 
Plate .a. CONTROL 
 
Section from the liver shows central veins surrounded by radiating cords of hepatocytes 
separated by sinusoids containing kuffer cells and portal triad shows lymphoid infiltrate. 
 
 
Plate .b. X group 
  
Section from the liver shows central veins surrounded by radiating cords of hepatocytes 
separated by sinusoids containing kuffer cells and portal triad shows lymphoid infiltrate. 
 
 
Plate .c. 5X group 
 
Section from the liver shows central veins surrounded by radiating cords of hepatocytes 
separated by sinusoids containing kuffer cells and portal triad shows lymphoid infiltrate. 
 
 
Plate .d. 10X group 
 
Section from the liver shows central veins surrounded by radiating cords of hepatocytes 
separated by sinusoids containing kuffer cells and portal triad shows lymphoid infiltrate. 
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LIVER 
    
                
        
 
 
     
 
            Plate.a. CONTROL                                                      Plate.b. X group 
 
                            
          Plate.c.5X group                          Plate.d.10X group 
 
 
                                                                                                                         
 Plate.e.10X group - high power             
                   shows lymphoid infiltrate 
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LUNG 
 
Plate .a. CONTROL 
 
Section from the lung shows normal appearing bronchioles, alveoli, intestitium and blood 
vessels. 
 
 
Plate .b. X group 
  
Section from the lung shows normal appearing bronchioles, alveoli, intestitium and blood 
vessels. 
 
 
 
Plate .c. 5X group 
 
Section from the lung shows normal appearing bronchioles, alveoli and focal lymphoid 
aggregates. 
 
 
Plate .d. 10X group 
 
Section of the lung shows normal appearing bronchioles, alveoli and focal lymphoid 
aggregates. 
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LUNG 
 
 
 
   
                       
 
 
 
 
 
 
 
 
 
          Plate.a. CONTROL                                                                          Plate.b. X group 
 
 
                              
         
 
 
                     Plate.c.5X group                                            Plate.d. 10X group 
  
 
 
       Plate.e. shows lymphoid infiltrate 
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STOMACH 
 
Plate .d. 10 Xgroup 
 
Section of the stomach shows gastric mucosa lined by tall columnar cells. The mucosa is 
ulcerated. Lamina propria shows diffused acute and chronic inflammatory cells. 
Muscularis mucosae and muscularis propria are normal. 
 
                            
  
Plate.d. 10 X scanner image                                                              Plate.d. 10 X ulcerated area 
 
 
SPLEEN 
 
Plate .d. 10X group 
 
Section from the spleen shows white pulp with lymphoid follicles and central arteriole. 
The red pulp is congested. 
 
                               
    Plate .d. 10X group-low power                                                    Plate.d. 10X group- central artery. 
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Table.6. Behavioral signs of Acute toxicity study in Swiss albino mice treated with Puttru Pathangam 
 
 
 
1. Alertness 2. Aggressiveness 3. Passivity. 4. Grooming 5. Gripping strength 6. Touch responses 
7.Restlessness 8. Tremors  9. Convulsion 10. Pain response 11.Defaecation 12. Pinna reflex13.Corneal 
reflex 14.Pupillary size15. Lacrimation 16. Salivation 17. Urination 18. Writhing 19.Skin colour 20. 
Mortality 
 
       + Presence of activity,   N - Normal,  
       –Absence of activity    A - Absent 
 
Table.7. Body wt (g) of Wister rats in Repeated oral dose toxicity study treated with      
Puttru Pathangam 
 
NS- Not Significant, *(p >0.05), n = 6 values are mean ± S.D (One way Anova followed by Dunnett’s test) 
 
 
 
No. 
 
 
 
 
Treatment 
group 
 
 
1 
 
 
2 
 
 
3 
 
 
4 
 
 
5 
 
 
6 
 
 
7 
 
 
8 
 
 
9 
 
 
10 
 
 
11 
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+ 
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N 
 
 
+ 
 
DOSE 
(mg/animal) 
 
DAYS 
1 7 14 21 28 
 
CONTROL 
 
119.50 ± 5.30 
 
115.60 ± 5.03 
 
118.05 ± 3.44 
 
122.50 ± 4.54 
 
130.15 ± 3.24 
 
X - GROUP 
 
112.33 ± 2.36 
 
114.01 ± 2.66 
 
120.48 ± 3.44 
 
124.60 ± 4.15 
 
132.13 ± 4.56 
 
5X - GROUP 
 
115.45 ± 4.12 
 
118.23 ± 3.44 
 
119.86 ± 3.50 
 
132.77 ± 3.33 
 
134.19 ± 4.53 
 
10 X -
GROUP 
 
114.40 ± 3.89 
 
118.22 ± 2.25 
 
124.76 ± 3.19 
 
133.47 ± 5.55 
 
135.13 ± 4.58 
 
P value (p)* 
 
NS 
 
NS 
 
NS 
 
NS 
 
NS 
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Table.8. Water intake (ml/day) of Wister rats in Repeated oral dose toxicity study treated with 
Puttru Pathangam 
 
 
DOSE 
(mg/animal) 
 
DAYS 
 
1 
 
7 
 
14 
 
21 
 
28 
 
CONTROL 
 
35.55 ± 2.54 
 
29.60 ± 2.83 
 
34.05 ± 3.59 
 
34.5 ± 4.57 
 
30.15 ± 3.24 
 
X - GROUP 
 
31.33 ±7.44 
 
31.01 ± 2.66 
 
34.48 ±  4.17 
 
32.61 ± 4.15 
 
37.23 ± 3.44 
 
5X - GROUP 
 
29.47 ± 3.89 
 
40.23 ± 3.36 
 
31.86 ± 3.89 
 
36.77 ± 3.33 
 
38.19 ± 4.53 
 
10 X - GROUP 
 
33.49 ± 4.58 
 
39.22 ± 4.25 
 
36.76 ± 3.09 
 
40.47 ± 5.55 
 
40.13 ± 4.12 
 
P value (p)* 
 
NS 
 
NS 
 
NS 
 
NS 
 
NS 
 
N.S- Not Significant, *(p >0.05), n = 6 values are mean ± S.D (One way Anova followed by Dunnett’s test) 
 
Table.9. Food (g/kg) intake of Wister rats in Repeated oral dose toxicity study treated with 
Puttru Pathangam 
 
 
DOSE 
(mg/animal) 
 
DAYS 
 
1 
 
7 
 
14 
 
21 
 
30 
 
CONTROL 
 
29.55 ± 3.24 
 
33.60 ± 3.55 
 
39.05 ± 3.25 
 
41.5 ±  2.05 
 
43.15 ± 4.76 
 
X - GROUP 
 
26.33 ±4.15 
 
39.01 ± 2.66 
 
34.48 ± 3.44 
 
     38.6  ± 3.89 
 
41.32 ± 4.11 
 
5X GROUP 
 
25.47 ± 4.12 
 
35.23 ± 3.44 
 
38.86 ± 3.89 
 
35.77 ± 2.36 
 
44.19 ± 4.53 
 
10 X 
GROUP 
 
28.49 ± 3.33 
 
31.22 ± 4.25 
 
35.76 ± 3.09 
 
33.47 ± 5.58 
 
41.13 ± 4.58 
 
P value (p)* 
 
NS 
 
NS 
 
NS 
 
NS 
 
NS 
 
N.S- Not Significant,* (p >0.05),n = 6 values are mean ± S.D (One way Anova followed by Dunnett’s test) 
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Table.10. Haematological parameters of Wister rats in Repeated oral dose toxicity study treated with 
Puttru Pathangam 
 
NS- Not Significant,* (p >0.05), ** S – Significant.  (p<0.05).  n = 6 values are: mean ± S.D 
 (One way Anova followed by Dunnett’s test) 
 
 
Table.11. Biochemical Parameters of Wister rats in Repeated oral dose toxicity study treated with  
Puttru Pathangam 
 
 
BIOCHEMICAL 
PARAMETERS 
CONTROL  X GROUP 
 
5X 
GROUP 
 
10X 
GROUP 
 
P Value 
(p)* 
 
GLUCOSE (R) (mg/dl) 
 
89.2 ± 28 
 
95.2±15 
 
116 ± 37 
 
93 ± 25 
 
N.S 
 
T.CHOLOSTEROL(mg/dl) 
 
86.1 ± 7.4 
 
70. ±10 
 
87 ± 5.2 
 
91 ± 4.3 
 
N.S 
 
HDL(mg/dl) 
 
20.2 ± 4.3 
 
23 ± 5.3 
 
22 ± 7.6 
 
23 ± 2.1 
 
N.S 
 
LDL(mg/dl) 
 
23.1 ± 5.7 
 
22 ± 8.3 
 
20 ± 6.5 
 
22 ± 6.3 
 
N.S 
 
VLDL(mg/dl) 
 
27.5 ± 4.5 
 
24 ± 4.4 
 
26 ± 6.4 
 
26 ± 5.3 
 
N.S 
 
TRIGLY(mg/dl) 
 
132.4 ± 20 
 
127 ± 17 
 
124 ± 28 
 
129 ±17 
 
N.S 
  
NS- Not Significant,* (p >0.05), n = 6 values are mean ± S.D (One way Anova followed by Dunnett’s test) 
 
 
     
 
 
Category 
 
 
 
 
Haemoglobin 
 
(g/dl) 
 
 
Total -WBC 
(cells/cu.mm) 
 
 
 
Diff.Count 
Neutrophil 
 
( %) 
 
Diff.Count 
Lymphocyte 
 
( %) 
 
Total - RBC 
 
(cells/cu.mm) 
 
 
CONTROL 
 
13.4 ± 0.6 
 
7056 ± 907 
 
23.3 ± 15.3 
 
55.4 ± 24.1 
 
7.2 ± 1.2 
 
X 
 
15.5 ± 2.2 
 
8250 ± 1203 
 
21.1 ± 9.3 
 
68.5 ± 9.2 
 
7.8 ± 1.2 
 
5X 
 
16.4 ± 3.5 
 
7850 ± 805 
 
24.7 ± 10.1 
 
70.6±  8.3 
 
8.1 ± 1.0 
 
10X 
 
15.0 ± 2.5 
 
9765 ± 1076 
 
24.5 ± 8.3 
 
77.3 ± 10.3 
 
7.9 ± 0.3 
P value 
(p)* NS NS NS 
NS, ** 
5X vs. X -S NS 
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Table.12. Renal function test of Wister rats in Repeated oral dose toxicity study treated with  
Puttru Pathangam 
PARAMETERS CONTROL X - GROUP 5X - GROUP 
10X - 
GROUP 
P Value 
(p)* 
UREA (mg/dl) 10 ± 5.5 16 ± 3.5 18.3±7.5 10.4 ± 6  N.S 
CREATININE 
(mg/dl) 0.76 ± 0.23 0.59 ± 0.15 0.76 ± 0.19 0.62 ± 0.12 
 
N.S 
URIC 
ACID(mg/dl) 2.71 ± 0.23 3.67 ± 0.36 2.38 ± 0.55 2.73 ± 0.47 
 
N.S 
CALCIUM(mg/dl) 8.5 ± 0.8 8.9 ± 1.8 7.7 ± 0.6 9.1 ± 2.3  N.S 
POTASSIUM 
(mg/dl) 2.6 ± 0.4 3.7 ± 0.5 2.6 ± 0.5 3.1 ± 0.6 
 
N.S 
 
 NS- Not Significant,* (p >0.05) , n = 6 values are mean ± S.D (One way Anova followed by Dunnett’s 
test) 
 
 
Table.13. Liver Function Test of Wister rats in Repeated oral dose toxicity study treated with 
 Puttru Pathangam 
PARAMETERS CONTROL X - GROUP 5X - GROUP 
10X - 
GROUP 
P Value 
(p)*  
 
T.BILIRUBIN(mg/dl) 
 
0.4 ± 0.1 
 
0.7 ± 0.1 
 
0.7 ± 0.2 
 
0.7 ± 0.2 
 
N.S 
 
D.BILIRUBIN(mg/dl) 
 
0.1 ± 0.0 
 
0.2 ± 0.1 
 
0.3 ± 0.3 
 
0.3 ± 0.1 
 
N.S 
 
I. BILIRUBIN(mg/dl) 
 
0.2 ± 0.1 
 
0.4 ± 0.1 
 
0.4 ± 0.2 
 
0.3 ± 0.2 
 
N.S 
 
SGOT(U/dl) 
 
67 ± 24 
 
64 ± 23 
 
58 ± 16 
 
57 ± 16 
 
N.S 
 
SGPT(U/dl) 
 
67 ± 11 
 
76 ± 25 
 
66 ± 23 
 
72 ± 22 
 
N.S 
 
ALP(U/dl) 
 
132 ± 6 
 
142 ± 15 
 
138 ± 18 
 
134 ± 20 
 
N.S 
 
T.PROTEIN(mg/dl) 
 
6.5 ± 0.9 
 
6.7 ± 0.3 
 
5.7 ± 0.5 
 
6.9 ± 0.3 
 
N.S 
 
ALBUMIN(mg/dl) 
 
3.1 ± 0.6 
 
4.1 ± 0.5 
 
3.2 ± 0.3 
 
3.6 ± 0.4 
 
N.S 
 
GLOBULIN(mg/dl) 
 
3.2 ± 0.7 
 
2.7 ± 0.2 
 
2.5 ± 0.7 
 
3.6 ± 0.3 
 
N.S 
 
     NS- Not Significant,* (p >0.05), n = 6 values are mean ± S.D (One way Anova followed by Dunnett’s 
test) 
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Chart.1. Mean arithmetic values of Control and test group animals 
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Chart.2. Mean arithmetic values of Control and test group animals 
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Chart.3. Mean arithmetic values of Control and test group animals 
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Chart.4. Mean arithmetic values of Control and test group animals 
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Chart.5. Mean arithmetic values of Control and test group animals 
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Chart.6. Mean arithmetic values of Control and test group animals 
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Chart.7. Mean arithmetic values of Control and test group animals 
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Chart.8. Mean arithmetic values of Control and test group animals 
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Chart.9. Mean arithmetic values of Control and test group animals 
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 DISCUSSION VI 
 
 In this study Puttru Pathangam was subjected to qualitative, quantitative and 
toxicity studies. Qualitative analysis includes physico chemical properties of Puttru 
Pathangam. Quantitative analysis includes ICP-OES, XRF, FTIR and SEM. And then 
finally both Acute and Repeated oral dose toxicity study were carried out in rodents as 
per OECD guidelines. 
Qualitative Analysis of the Puttru Pathangam showed the presence of phosphate, 
Iron, chloride and unsaturated compound.  
  In the Physico Chemical Analysis, the pH of Puttru Pathangam was 3.2 -3.5. It 
denotes acidity. Thus, on oral intake it may be easily absorbed from the gastrointestinal 
tract. The loss on drying at 105ºC was only 13.34% w/w; hence the drug will not lose 
much of its volume on exposure to atmospheric air at room temperature. Solubility of 
Puttru Pathangam was found to be increased compared to the purified and unpurified 
ingredients of it. Hence there is possibility of increased absorption. 
  In ICP-OES study, heavy metals like As, Pb, Cd were found below detection 
limit in Puttru Pathangam. Mercury, calcium, iron, potassium, phosphorous, sodium were 
present. (Table.4)  
In XRF analysis (Table.5), the heavy elements in Puttru Pathangam were within 
normal limits when compared to ICP OES. 
FTIR analysis of Puttru Pathangam indicates the addition of primary and 
secondary amines, aromatics, alkyl halides and alkynes. This indicates the drug attained 
to fulfill its therapeutic value.(Table.6)  
 HR SEM analysis of Puttru Pathangam reveals that the particle size is 0.25-
0.5µ(micron). The particles were homogenously distributed in the Pathangam. And 
smooth surface of the particles enable easy absorption in the gastro intestinal tract. Hence 
the drug will have increased bioavailability.(Fig.4.) 
 Mercury was detected in level in the finally prepared medicine Puttru Pathangam 
as (3.842). But the arsenic as an ingredient, it was found below the detection limit. This 
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indicates that all heavy metals in Puttru Pathangam were within normal range and near to 
permissible limit. So that Puttru Pathangam is safe for human consumption. (Table.4.)  
  In Acute oral dose toxicity study period there were no abnormal signs developed 
in 5mg 50mg treated animals. No mortality and reduction in body weight of animals were 
observed in 5mg and 50mg groups. In the group of 300mg/kg, very high dose when 
compare with Human therapeutic dose (65mg), mortality was observed in two animals. 
So the LD50 of Puttru Pathangam is 200mg/kg body weight as per OECD guidelines. 
(Table.7.)            
 At the end of Repeated oral dose toxicity study animals were sacrificed and 
blood samples were collected and investigated. The organs were collected and sent for 
histopathology study. All the reports were statistically calculated. There were no 
significant changes in hematological parameters, biochemical investigations, body 
weight, food and water intake. There was a marked increase in lymphocyte count in test 
groups, but compared to control group, it is not statistically significant. (Table.8-13).  
Gross pathological examination of animals doesn’t reveal any abnormalities in 
control and test groups.           
             The histopathological study of the organs such as heart, lungs, kidney, spleen, 
stomach and liver was normal in control, X, and 5X groups. In 10X group, lung shows 
focal lymphoid aggregation. Liver shows portal tract with focal lymphoid infiltrate, 
radiating cords of hepatocytes, sinusoids were normal. Stomach shows acute and chronic 
inflammatory cells in lamina propria. Heart shows normal myocardial fibers with 
patterned coronaries.  
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 SUMMARY VII 
 
  
 Siddha system is the ancient traditional system followed in South India mainly in 
Tamilnadu.   In Siddha system of medicine Plants, minerals and Metals play an important 
role. Mercurial compound has also been practised in Siddha system from time 
immemorial.  Rasam, Gandhagam, Lingam, Thaalagam, Manosilai, Vellai paadanam, 
Pooram, Gaantham and Saathikai.Puttru Pathangam is one of the notable medicine in the 
treatment of cancer. The name itself tells. Puttru Pathangam taken from the literature 
Anuboga Vaithiya Navaneetham, part-10, is also used in the treatment of various types 
of cancer as in cheek, breast, mouth cancer, sexual organs, cancer in legs, vellai kuttam 
(vitiligo) and kandamaalai (cervical adenitis).          
  The raw drug was procured from country drug shop from Kanyakumari and 
authenticated at Siddha Central Research Institute and the plant drugs authenticated in 
Department of Medicinal Botany in NIS. The drugs were purified and the medicine was 
prepared as mentioned in the Siddha literature at Gunapaadam laboratory in NIS.  
 Chemical analysis of the drug Puttru Pathangam confirmed the presence of 
phosphate, Iron, chloride and unsaturated compound. 
In physico - chemical analysis of Puttru Pathangam the pH was found to be 3.2 -
3.5 and the loss on drying at 105ºC was 13.34% w/w. 
 In ICP-OES study, heavy metals like As, Pb, Cd were found below detection limit 
in Puttru Pathangam. Mercury, calcium, iron, potassium, phosphorous, sodium were 
present. Mercury was detected in minimal level in the finally prepared medicine Puttru 
Pathangam as (3.842). 
 In XRF analysis the heavy elements in Puttru Pathangam were found within 
normal limits when compared to ICP OES. 
 By the HR SEM analysis, the particle size of the Puttru Pathangam was analyzed 
as 0.25-0.5 µ (micron). 
 The toxicological evaluations were conducted at Animal house of NIS, as per 
OECD guidelines for safety evaluation of Puttru Pathangam.  
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In Acute oral dose toxicity study period there were no abnormal signs developed 
in 5mg 50mg treated animals. No mortality and reduction in body weight of animals were 
observed in 5mg and 50mg groups. In the group of 300mg/kg, very high dose when 
compare with Human therapeutic dose (65mg), mortality was observed in two animals. 
So the LD50 of Puttru Pathangam is 200mg/kg body weight as per OECD guidelines.  
 At the end of Repeated oral dose toxicity study animals were sacrificed by 
excessive anesthesia and blood samples were collected and investigated. The organs were 
collected and sent for histopathology study. All the reports were statistically calculated. 
There were no significant changes in hematological parameters, biochemical 
investigations, body weight, food and water intake.(Table 7-13) There was a marked 
increase in lymphocyte count in the test groups, but compared to control group, it is not 
statistically significant. (Table.10) 
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 CONCLUSION VII 
 
 
 As the result of this study, it has been concluded that  
 Though the white arsenic is an ingredient, it was found to below the detection 
level in the prepared medicine analyzed by sophisticated instrument. It reveals the 
potential background of Siddhars knowledge in the field of metals, minerals and herbal 
usage in medicine preparation. Mainly the mercurial content of the prepared medicine 
Puttru Pathangam showed is less as an ingredient (3.842).  
 The acute and repeated oral dose toxicity of Puttru Pathangam is found to be less 
toxic and the therapeutic dose level mentioned in the literature is a safer dose for human 
consumption.  
 Hence further studies on Puttru Pathangam(Indicated mainly for cancer) are to be 
conducted for its scientific validation and global acceptance. 
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